Document:

EX-4.2

 Exhibit 4.2 

BOX, INC. 
 EIGHTH
AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 
 July 7, 2014 

 TABLE OF CONTENTS 

 

									
	1.	  	Registration Rights	  	 	2	 
		  	1.1	  	 Definitions
	  	 	2	 
		  	1.2	  	 Request for Registration
	  	 	4	 
		  	1.3	  	 Company Registration
	  	 	6	 
		  	1.4	  	 Form S-3 Registration
	  	 	8	 
		  	1.5	  	 Obligations of the Company
	  	 	10	 
		  	1.6	  	 Information from Holder
	  	 	11	 
		  	1.7	  	 Expenses of Registration
	  	 	11	 
		  	1.8	  	 Delay of Registration
	  	 	12	 
		  	1.9	  	 Indemnification
	  	 	12	 
		  	1.10	  	 Reports Under the 1934 Act
	  	 	15	 
		  	1.11	  	 Assignment of Registration Rights
	  	 	15	 
		  	1.12	  	 Limitations on Subsequent Registration Rights
	  	 	15	 
		  	1.13	  	 Market Stand-off Agreement
	  	 	16	 
		  	1.14	  	 Termination of Registration Rights
	  	 	16	 
		  	1.15	  	 Definitions After Initial Offering
	  	 	17	 
			
	2.	  	Covenants	  	 	17	 
		  	2.1	  	 Delivery of Financial Statements
	  	 	17	 
		  	2.2	  	 Inspection
	  	 	18	 
		  	2.3	  	 Right of First Offer
	  	 	18	 
		  	2.4	  	 Observer Rights
	  	 	21	 
		  	2.5	  	 Expenses
	  	 	22	 
		  	2.6	  	 Board Committees; Executive Compensation and Related Party Transactions
	  	 	22	 
		  	2.7	  	 Stock Option Vesting
	  	 	22	 
		  	2.8	  	 Proprietary Information and Inventions Agreement
	  	 	22	 
		  	2.9	  	 Drag-Along Rights
	  	 	22	 
		  	2.10	  	 Legal Fees and Expenses
	  	 	24	 
		  	2.11	  	 Directors’ Liability and Indemnification
	  	 	24	 
		  	2.12	  	 Lock-Up Agreement
	  	 	25	 
		  	2.13	  	 Voting Agreement
	  	 	25	 
		  	2.14	  	 Assignment of Right of First Refusal
	  	 	25	 
		  	2.15	  	 Termination of Covenants
	  	 	25	 
			
	3.	  	Miscellaneous	  	 	26	 
		  	3.1	  	 Legend
	  	 	26	 
		  	3.2	  	 Successors and Assigns
	  	 	26	 
		  	3.3	  	 Governing Law
	  	 	26	 
		  	3.4	  	 Counterparts
	  	 	26	 
		  	3.5	  	 Titles and Subtitles
	  	 	26	 
		  	3.6	  	 Notices
	  	 	26	 
		  	3.7	  	 Entire Agreement; Amendments and Waivers
	  	 	27	 

  
 i 

									
		  	3.8	  	Severability	  	 	28	 
		  	3.9	  	Aggregation of Stock	  	 	28	 
		  	3.10	  	Expenses	  	 	29	 
		  	3.11	  	Further Assurances	  	 	29	 
		  	3.12	  	Arbitration	  	 	29	 

  

			
	SCHEDULE A	 	Schedule of Existing Investors
	SCHEDULE B	 	Schedule of Series E-1 Holders
	SCHEDULE C	 	Schedule of Series F Holders
	SCHEDULE D	 	Schedule of Founders

  
 ii 

 BOX, INC. 

EIGHTH AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 

This Eighth Amended and Restated Investors’ Rights Agreement (this “Agreement”) is made as of the 7th day of
July, 2014 (the “Closing”), by and among Box, Inc., a Delaware corporation (the “Company”), the holders of shares of Series A Preferred Stock (the “Series A
Preferred”) listed on Schedule A hereto, each of whom is herein referred to as a “Series A Holder,” the holders of shares of Series B Preferred Stock (the “Series B
Preferred”) listed on Schedule A hereto, each of whom is herein referred to as a “Series B Holder,” the holders of shares of Series C Preferred Stock (the “Series C
Preferred”) listed on Schedule A hereto, each of whom is herein referred to as a “Series C Holder,” the holders of shares of Series D Preferred Stock (the “Series D
Preferred”) listed on Schedule A hereto, each of which is herein referred to as a “Series D Holder,” the holders of shares of Series D-1 Preferred
Stock (the “Series D-1 Preferred”) listed on Schedule A hereto, each of which is herein referred to as a
“Series D-1 Holder,” the holders of shares of Series D-2 Preferred Stock (the
“Series D-2 Preferred”) listed on Schedule A hereto, each of which is herein referred to as a “Series D-2
Holder,” the holders of shares of Series E Preferred Stock (the “Series E Preferred”) listed on Schedule A hereto, each of which is herein referred to as a “Series E
Holder,” the holders of shares of Series E-1 Preferred Stock (the “Series E-1 Preferred”) listed on Schedule B
hereto, each of which is herein referred to as a “Series E-1 Holder”, and the holders of shares of Series F Preferred Stock (the “Series F Preferred”)
listed on Schedule C hereto, each of which is herein referred to as a “Series F Holder,” who together with the Series A Holders, the Series B Holders, the Series C Holders, the Series D Holders, the
Series D-1 Holders, the Series D-2 Holders, the Series E Holders, and the Series E-1 Holders shall be referred to herein as the
“Investors,” certain holders of Class A Common Stock of the Company (the “Class A Common”) and Class B Common Stock of the Company (the “Class B Common,” and
together with the Class A Common, the “Common Stock”) listed on Schedule D hereto (the “Founders”) and Hercules Technology Growth Capital, Inc., a Maryland corporation
(“Hercules”). 
 RECITALS 

WHEREAS, the Company, the Series A Holders, the Series B Holders, the Series C Holders, the Series D Holders, the Series D-1 Holders, the Series D-2 Holders, the Series E Holders, the Series E-1 Holders, the Founders and Hercules have entered into a Seventh Amended and
Restated Investors’ Rights Agreement, dated as of October 15, 2013 (the “Existing Investors’ Rights Agreement”) and desire to amend and restate the Existing Investors’ Rights Agreement in its entirety in
accordance with Section 3.7 thereof; 
 WHEREAS, the Company and the Series F Holders executed a Series F Preferred Stock
Purchase Agreement dated as of July 3, 2014 (as may be amended from time to time, the “Purchase Agreement”), pursuant to which the Series F Holders intend to purchase and the Company intends to sell shares of the
Series F Preferred; 

 WHEREAS, the execution of this Agreement on or by the Closing (as defined in the Purchase
Agreement) is a condition of the Company’s and the Series F Holders’ mutual obligations at the Closing; and 
 WHEREAS, in
order to induce the Company, the Series A Holders, the Series B Holders, the Series C Holders, the Series D Holders, the Series D-1 Holders, the
Series D-2 Holders, the Series E Holders, and the Founders to approve the issuance of the Series F Preferred and to induce the Series F Holders to invest funds in the Company pursuant to
the Purchase Agreement, the Investors, the Founders and the Company hereby agree that this Agreement shall govern the rights of the Investors and the Founders to cause the Company to register shares of Common Stock issuable or issued to them and
certain other matters as set forth herein. 
 NOW, THEREFORE, in consideration of the premises and the mutual covenants herein contained,
and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereby agree as follows: 

AGREEMENT 
  

	1.	Registration Rights 

  

	 	1.1	Definitions 

 For purposes of this Agreement: 

(a) The term “Act” means the Securities Act of 1933, as amended. 

(b) The term “affiliate” includes, as that term is defined in Rule 405 of the Securities Act, any general
partner, officer, director or managers of such holder, and any venture capital fund or private equity fund now or hereafter existing that is controlled by or under common control with one or more managers or general partners of or managing members
of or shares the same management company with such holder. 
 (c) The term “Change of Control” shall have the same
meaning as the term “Deemed Liquidation” as defined in the Company’s Amended and Restated Certificate of Incorporation as in effect as of the date hereof. 

(d) The term “Coatue Stockholders” means Coatue Management, L.L.C., Coatue Private Fund I LP, and any of their
affiliates that hold Registrable Securities. 
 (e) The term “Form S-3” means such form under the Act as in effect
on the date hereof or any successor registration form under the Act subsequently adopted by the SEC that permits inclusion or incorporation of substantial information by reference to other documents filed by the Company with the SEC. 

(f) The term “General Atlantic Stockholders” means General Atlantic Partners 90, L.P., GAP Coinvestments III, LLC, GAP
Coinvestments IV, LLC, GAP Coinvestments CDA, L.P., GAPCO GmbH & Co. KG and any affiliated investment fund of the foregoing entities that holds Registrable Securities. 

  
 2 

 (g) The term “Holder” means any person owning of record or having the
right to acquire Registrable Securities or any assignee of record thereof to whom registration rights are assigned in accordance with Section 1.11 hereof, provided, however, that the Founders shall not be deemed to be Holders for
the purposes of Sections 1.2, 1.4, 1.12, 2, or 3.7 of this Agreement. 
 (h) The term “1934 Act” means the
Securities Exchange Act of 1934, as amended. 
 (i) The term “register,” “registered” and
“registration” refer to a registration effected by preparing and filing a registration statement in compliance with the Act, and the declaration or ordering of effectiveness of such registration statement or document. 

(j) The term “Registrable Securities” shall mean (i) the Common Stock issuable or issued upon conversion of the
Series A Preferred, Series B Preferred, Series C Preferred, Series D Preferred, Series D-1 Preferred, Series D-2 Preferred, Series E
Preferred, Series E-1 Preferred, or Series F Preferred (collectively, the “Preferred Stock”) held from time to time by the Investors and their permitted assigns, (ii) any
shares of Class A Common hereinafter acquired by a Holder pursuant to the exercise of such Holder’s right of first refusal in accordance with the terms and conditions of the Eighth Amended and Restated Right of First Refusal and Co-Sale
Agreement by and among the Company, the Founders (as defined therein) and the Investors (as defined therein) of even date herewith (including shares of Class B Common that are automatically converted into shares of Class A Common upon such
acquisition), (iii) any shares of Class A Common held by the Founders as of the date hereof or which may hereafter be acquired by the Founders from the Company, (iv) any shares of Class A Common of the Company issuable or issued
upon conversion of the Series B Preferred Stock issued upon exercise of the Hercules Technology II, L.P. warrant, (v) any shares of Class A Common of the Company issuable or issued upon conversion of the Series C Preferred Stock
issued upon exercise of the Hercules Technology Growth Capital, Inc. warrant, (vi) any shares of Class A Common of the Company issuable or issued upon conversion of the Series D-1 Preferred
Stock issued upon exercise of the Hercules Technology Growth Capital, Inc. warrant, (vii) any shares of Class A Common of the Company which may hereafter be acquired by the Investors (including shares of Class B Common that are
automatically converted into shares of Class A Common upon such acquisition); and (viii) any shares of Class A Common of the Company issued as (or issuable upon the conversion or exercise of any warrant, right or other security that
is issued as) a dividend or other distribution with respect to, or in exchange for, or in replacement of, the shares referenced in (i), (ii), (iii), (iv), (v), (vi) or (vii) above (including shares of Class B Common that are
automatically converted into shares of Class A Common upon issuance to the Investors), provided, however, that the foregoing definition shall exclude in all cases any Registrable Securities sold by a person in a transaction in
which his, her or its registration rights under this Agreement are not assigned in accordance with Section 1.11; provided, further, that the shares of Common Stock referenced in (iii) above (including shares issued as a
dividend or other distribution with respect thereto) shall not be deemed Registrable Securities for the purposes of Sections 1.2, 1.4, 1.12, 2 and 3.7 of this Agreement; provided, further, that the shares of Class A Common
referred to in (iv), (v) and/or (vi) above (including shares issued as a dividend or other distribution with respect thereto) shall not be deemed Registrable Securities for the purposes of Sections 2 and 3.7. In addition, shares of
Class A Common or other securities shall only be treated as Registrable Securities if and so long as they have not been (A) sold to or 

  
 3 

 
through a broker or dealer or underwriter in a public distribution or a public securities transaction, including sales made pursuant to Rule 144 promulgated under the Act, or (B) sold in a
transaction exempt from the registration and prospectus delivery requirements of the Act under Section 4(1) thereof so that all transfer restrictions, and restrictive legends with respect thereto, if any, are removed upon the consummation of
such sale. The number of shares of Registrable Securities deemed to be outstanding at any given time shall be the sum of the number of shares of Class A Common outstanding that are Registrable Securities plus the number of shares of
Class A Common issuable upon the conversion of the Preferred Stock or pursuant to the exercise of other convertible securities that are Registrable Securities hereunder. 

(k) The term “SEC” shall mean the Securities and Exchange Commission. 

(l) The term “TPG Stockholders” means TPG Bogota Holdings, L.P. and any of its affiliates that hold Registrable
Securities. 
  

	 	1.2	Request for Registration 

 (a) Subject to the conditions of this Section 1.2,
if the Company shall receive (i) at any time after the first anniversary of the effective date of the Company’s first firm commitment underwritten public offering of its Common Stock under the Act (the “Initial
Offering”), or August 7, 2015, whichever is earlier, a written request from either (x) the General Atlantic Stockholders or (y) the Holders of at least a majority of the Registrable Securities then outstanding, and
(ii) at any time after the Initial Offering, the TPG Stockholders, (in either case of (i) or (ii), hereinafter, the “Initiating Holders”) that the Company file a registration statement under the Act covering the
registration of Registrable Securities that constitute at least twenty percent (20%) of the Initiating Holders’ Registrable Securities or Registrable Securities with an anticipated aggregate offering price of at least $2,000,000, then the
Company shall, promptly but not later than twenty (20) days after the receipt thereof, give written notice of such request to all Holders, and subject to the limitations of this Section 1.2, use all reasonable efforts to effect, as soon as
practicable, the registration under the Act of all Registrable Securities that the Holders request to be registered in a written request received by the Company within twenty (20) days of the mailing of the Company’s notice pursuant to
this Section 1.2(a) (including, without limitation, filing post-effective amendments, appropriate qualifications under applicable blue sky or other state securities laws, and appropriate compliance with the Act), and use all reasonable efforts
to permit or facilitate the sale and distribution of all or such portion of such Registrable Securities as are specified in such request. 

(b) If the Initiating Holders intend to distribute the Registrable Securities covered by their request by means of an underwriting, they shall
so advise the Company as a part of their request and the Company shall include such information in the written notice referred to in Section 1.2(a), except, in the case of a Shelf Registration Statement, such request may be made at any time
during the effectiveness of such Shelf Registration Statement and the Company shall notify the Holders promptly following such a request. In such event the right of any Holder to include its Registrable Securities in such registration shall be
conditioned upon such Holder’s participation in such underwriting and the inclusion of such Holder’s Registrable Securities in the underwriting (unless otherwise mutually agreed by a majority in interest of the Initiating Holders and such
Holder) to the extent provided herein; provided, that in the case of a Shelf Registration 

  
 4 

 
Statement, a request of an underwritten distribution shall not affect the rights of any Holders to include their Registrable Securities in such Shelf Registration Statement, but the right of the
Holders to participate in such underwritten distribution shall be conditioned upon their participation in such underwriting, as provided herein. Notwithstanding any other provision of this Section 1.2, if the underwriter advises the Company
that marketing factors require a limitation of the number of securities underwritten (including Registrable Securities), then the Company shall so advise all Holders of Registrable Securities that would otherwise be underwritten pursuant hereto, and
the number of shares that may be included in the underwriting shall be allocated to the Holders of such Registrable Securities on a pro rata basis based on the number of Registrable Securities held by all such Holders (including the Initiating
Holders), provided, however, that the number of shares of Registrable Securities to be included in such underwriting shall not be reduced unless all other securities are first entirely excluded from the underwriting and registration.
Any Registrable Securities excluded or withdrawn from such underwriting shall be withdrawn from the registration. The Company shall (together with all Holders proposing to distribute their securities through such underwriting) enter into an
underwriting agreement in customary form with the representative of the underwriter or underwriters selected for such underwriting by a majority in interest of the Initiating Holders, which underwriters are reasonably acceptable to the Company. 

If a person who has requested inclusion in such registration as provided above does not agree to the terms of any such underwriting, such
person shall be excluded therefrom by written notice from the Company, the underwriter or the Initiating Holders. Any Registrable Securities or other securities excluded or withdrawn from such underwriting shall also be withdrawn from such
registration, except in the case of a Shelf Registration Statement. If shares are so withdrawn from the registration or underwriting and if the number of shares to be included in such registration or underwriting was previously reduced as a result
of marketing factors pursuant to this Section 1.2, then the Company shall then offer to all Holders who have retained rights to include securities in the registration or underwriting the right to include additional Registrable Securities in the
registration or underwriting in an aggregate amount equal to the number of shares so withdrawn, with such shares to be allocated among such Holders requesting additional inclusion based on the pro rata percentage of Registrable Securities held by
such Holders assuming conversion. 
 (c) The Company shall not be required to effect a registration pursuant to this Section 1.2: 

(1) in any particular jurisdiction in which the Company would be required to execute a general consent to service of process in effecting
such registration, unless the Company is already subject to service in such jurisdiction, and except as may be required under the Act; or 

(2) if such registration is requested by the General Atlantic Stockholders, after the Company has effected one (1) registration
requested by the General Atlantic Stockholders pursuant to this Section 1.2, and such registrations have been declared or ordered effective and pursuant to which securities have been sold; or 

  
 5 

 (3) if such registration is requested by the TPG Stockholders, after the Company has effected
one (1) registration requested by the TPG Stockholders pursuant to this Section 1.2, and such registrations have been declared or ordered effective and pursuant to which securities have been sold; or 

(4) if such registration is requested by the Holders of at least a majority of the Registrable Securities then outstanding, after the Company
has effected two (2) registrations requested by such Holders pursuant to this Section 1.2, and such registrations have been declared or ordered effective and pursuant to which securities have been sold; or 

(5) during the period starting with the date sixty (60) days prior to the Company’s good faith estimate of the date of the filing
of, and ending on the date one hundred eighty (180) days following the effective date of a Company-initiated registration subject to Section 1.3 below, provided that the Company is actively employing in good faith all reasonable
efforts to cause such registration statement to become effective; or 
 (6) if the Initiating Holders propose to dispose of Registrable
Securities that may be registered on Form S-3 pursuant to Section 1.4 hereof; or 
 (7) if the Company shall furnish to Holders
requesting a registration statement pursuant to this Section 1.2, a certificate signed by the Company’s Chief Executive Officer or Chairman of the Board stating that in the good faith judgment of the Board of Directors of the Company, it
would be materially detrimental to the Company and its stockholders for such registration statement to be effected at such time, in which event the Company shall have the right to defer such filing for a period of not more than ninety (90) days
after receipt of the request of the Initiating Holders, provided that such right to delay a request shall be exercised by the Company not more than once in any twelve-month (12) period, and provided, further, that the
Company shall not register any securities for the account of itself or any other stockholder during such ninety (90) day period (other than a registration relating solely to the sale of securities of participants in a Company stock plan or a
registration relating solely to an acquisition under Rule 145 of the Act). 
  

	 	1.3	Company Registration 

 (a) If the Company proposes to register (including for this
purpose a registration initiated by the Company for stockholders other than the Holders) any of its stock or other securities under the Act in connection with the public offering for cash of such securities (other than a registration relating solely
to the sale of securities to participants in a Company stock plan, a registration relating to a corporate reorganization or other transaction under Rule 145 of the Act, or a registration in which the only Common Stock being registered is Common
Stock issuable upon conversion of debt securities that are also being registered), the Company shall, at such time, notify each Holder in writing at least forty-five (45) days prior to such registration. Upon the written request of each Holder
given within fifteen (15) days after delivery of such notice by the Company in accordance with Section 3.6, the Company shall, subject to the provisions of Section 1.3(c), use all reasonable efforts to cause to be registered under the
Act all of the Registrable Securities that each such Holder has requested to be registered. 

  
 6 

 Each Holder’s written request shall state the number of Registrable Securities such Holder
wishes to include in such registration statement. Holders that do not elect to participate in any registration and underwriting under this Section 1.3 shall nevertheless continue to have the right to include any Registrable Securities in
subsequent registrations and underwritings to which this Section 1.3 is applicable. 
 (b) Right to Terminate
Registration. The Company shall have the right to terminate or withdraw any registration initiated by it under this Section 1.3 prior to the effectiveness of such registration whether or not any Holder has elected to include securities
in such registration. The expenses of such withdrawn registration shall be borne by the Company in accordance with Section 1.7 hereof. 

(c) Underwriting Requirements. The Company shall not be required to include in any registration and underwriting to which this
Section 1.3 is applicable, the Registrable Securities of any Holder that fails to execute the underwriting agreement entered into between the Company and the underwriter or underwriters selected by it. In addition, the Company shall be required
to include in the offering only that number of Registrable Securities that the underwriters determine in good faith will not jeopardize the success of the offering (the securities so included to be apportioned pro rata among the selling Holders
according to the total amount of securities entitled to be included therein owned by each selling Holder or in such other proportions as shall mutually be agreed to by such selling Holders), but in no event shall (i) the amount of securities of
the selling Holders included in the offering be reduced below thirty percent (30%) of the total amount of securities included in such offering, unless such offering is the Initial Offering, in which case the selling Holders may be completely
excluded if the underwriters make the determination described above and no other stockholder’s securities are included, (ii) any securities held by Founders be included if any securities held by Investors are excluded, or (iii) the
number of shares of Registrable Securities to be included in such underwriting be reduced unless all other securities (other than those of the Company) are first entirely excluded from the underwriting. For purposes of the preceding provision
concerning apportionment, for any selling stockholder that is a Holder of Registrable Securities and that is a venture capital fund, private equity fund, partnership, limited liability company or corporation, the affiliated venture capital funds,
private equity funds, partners, retired partners, members and stockholders of such Holder, or the estates and family members of any such partners, retired partners, members and any trusts for the benefit of any of the foregoing persons shall be
deemed to be a single “selling Holder,” and any pro rata reduction with respect to such “selling Holder” shall be based upon the aggregate amount of Registrable Securities owned of record by all such related entities and
individuals. 
 If a person who has requested inclusion in such registration as provided above does not agree to the terms of any such
underwriting, such person shall also be excluded therefrom by written notice from the Company or the underwriter. The Registrable Securities or other securities so excluded shall also be withdrawn from such registration. Any Registrable Securities
or other securities excluded or withdrawn from such underwriting shall be withdrawn from such registration. If shares are so withdrawn from the registration and if the number of shares of Registrable Securities to be included in such registration
was previously reduced as a result of marketing factors pursuant to Section 1.3, the Company shall then offer to all persons who have retained the right to include securities in the registration the right to include additional

  
 7 

 
securities in the registration in an aggregate amount equal to the number of shares so withdrawn, with such shares to be allocated among (i) first, the Holders requesting to include
Registrable Securities in such registration statement based on the pro rata percentage of Registrable Securities held by such Holders, assuming conversion, and (ii) second, others requesting to include shares in such registration statement
based on the pro rata percentage of shares held by such person, assuming conversion. 
 (d) No Demand Registration.
Registration pursuant to this Section 1.3 shall not be deemed to be a request for registration as described in Sections 1.2 and 1.4 hereof. Except as otherwise provided herein, there shall be no limit on the number of times the Holders may
request registration of Registrable Securities under this Section 1.3. 
  

	 	1.4	Form S-3 Registration 

 (a) After its Initial Offering, the Company shall use its
commercially reasonable efforts to qualify for registration on Form S-3 or any comparable or successor form or forms. In case the Company shall receive from any of the Holders a written request or requests that the Company effect a registration on
Form S-3 and any related qualification or compliance with respect to all or a part of the Registrable Securities owned by such Holder or Holders, the Company shall: 

(1) promptly give written notice of the proposed registration, and any related qualification or compliance, to all other Holders of
Registrable Securities; and 
 (2) use all reasonable efforts to effect, as soon as reasonably practicable, such registration and all such
qualifications and compliances as may be so requested and as would permit or facilitate the sale and distribution of all or such portion of such Holders’ Registrable Securities as are specified in such request, together with all or such portion
of the Registrable Securities of any other Holders joining in such request as are specified in a written request given within fifteen (15) days after receipt of such written notice from the Company. 

(b) Holders of Registrable Securities requesting a registration on Form S-3 or any comparable or successor form or forms pursuant to this
Section 1.4 shall have the right to elect for any such registration to be made for an offering to be made on a continuous or delayed basis pursuant to Rule 415 covering the Registrable Securities (a “Shelf Registration
Statement”), in which case the registration statement filed by the Company in connection with such request shall be a Shelf Registration Statement. The Company shall use its best efforts to keep the Shelf Registration Statement continuously
effective in order to permit the Prospectus forming a part thereof to be usable by the Holders for a period of 12 months plus the period of time, if any, during which use of such Shelf Registration Statement has been suspended pursuant to
Section 1.4(c)(3) or, if earlier, until the distribution contemplated in the Shelf Registration Statement has been completed. 
 (c)
The Company shall not be obligated to effect any such registration, qualification or compliance, pursuant to this Section 1.4: 
 (1)
if Form S-3 is not available for use by the Company with respect to such offering by the Holders; 

  
 8 

 (2) if the Holders, together with the holders of any other securities of the Company entitled to
inclusion in such registration, propose to sell Registrable Securities and such other securities (if any) at an aggregate price to the public of less than $500,000; 

(3) if the Company shall furnish to the Holders a certificate signed by the Chief Executive Officer or Chairman of the Board of the Company
stating that in the good faith judgment of the Board of Directors of the Company, it would be materially detrimental to the Company and its stockholders for such Form S-3 Registration to be effected (or, in the case of a Shelf Registration Statement
(as defined above), either effected or used) at such time, in which event the Company shall have the right to defer the filing of the Form S-3 registration statement (or, in the case of an already effective Shelf Registration Statement, direct the
Holders to suspend sales pursuant to such already effective Shelf Registration Statement) for a period of not more than sixty (60) days after receipt of the request of the Holder or Holders under this Section 1.4 (or, in the case of an
already effective Shelf Registration Statement, after such determination by the Board of Directors of the Company), provided, however, that the Company shall not utilize this right more than once in any twelve (12) month period
and provided, further, that the Company shall not register any securities for the account of itself or any other stockholder during such sixty (60) day period (other than a registration relating solely to the sale of securities of
participants in a Company stock plan or a registration relating solely to an acquisition under Rule 145 of the Act); 
 (4) if the Company
has, within the twelve (12) month period preceding the date of such request, already effected two (2) registrations on Form S-3 for the Holders pursuant to this Section 1.4; or 

(5) in any particular jurisdiction in which the Company would be required to qualify to do business or to execute a general consent to
service of process in effecting such registration, qualification or compliance. 
 (d) If the Holders intend to distribute the Registrable
Securities covered by their request by means of an underwriting, they shall so advise the Company as a part of their request made pursuant to this Section 1.4 and the Company shall include such information in the written notice referred to in
Section 1.4(a). The provisions of Section 1.2(b) shall be applicable (as relevant) to such request (with the substitution of Section 1.4 for references to Section 1.2). For the avoidance of doubt, in the case of a Shelf
Registration Statement, any of the Holders may make such a request for some or all of the registered Registrable Securities at any time that the Shelf Registration Statement is effective and the Company shall amend or supplement the Shelf
Registration Statement as may be necessary in order to enable such underwritten distribution. 
 (e) Subject to the foregoing, the Company
shall file a Form S-3 registration statement covering the Registrable Securities and other securities so requested to be registered as soon as practicable after receipt of the request or requests of any of the Holders. Registrations effected
pursuant to this Section 1.4 shall not be counted as requests for registration effected pursuant to Section 1.2. Except as otherwise provided herein, there shall be no limit on the number of times the Holders may request registration of
Registrable Securities under this Section 1.4. 

  
 9 

	 	1.5	Obligations of the Company 

 Whenever required under this Section 1 to effect
the registration of any Registrable Securities, the Company shall, as expeditiously as reasonably possible: 
 (a) prepare and file with the
SEC a registration statement with respect to such Registrable Securities not later than 45 days after a registration is requested pursuant to Section 1.2 or Section 1.4 hereof, and use all reasonable efforts to cause such registration
statement to become effective, and, upon the request of the Holders of a majority of the Registrable Securities registered thereunder, keep such registration statement effective for a period of one hundred twenty (120) days or, if earlier,
until the distribution contemplated in the Registration Statement has been completed; provided, however, that (i) such 120-day period shall be extended for a period of time equal to the period the Holders refrain from selling any
securities included in such registration at the request of the managing underwriter of such offering; and (ii) in the case of any Shelf Registration Statement, the provisions of Section 1.4(b) hereof shall apply; 

(b) prepare and file with the SEC such amendments and supplements to such registration statement and the prospectus used in connection with
such registration statement as may be necessary or advisable to comply with the provisions of the Act with respect to the disposition of all securities covered by such registration statement for the period set forth in paragraph (a) above; 

(c) furnish to the Holders (and to the underwriters, if applicable) such numbers of copies of a prospectus, including a preliminary
prospectus, in conformity with the requirements of the Act, and such other documents as they (or the underwriters, if applicable) may reasonably request in order to facilitate the disposition of Registrable Securities owned by them; 

(d) use its reasonable best efforts to register and qualify the securities covered by such registration statement under such other securities
or “blue sky” laws of such jurisdictions as shall be reasonably requested by the Holders, provided that the Company shall not be required in connection therewith or as a condition thereto to qualify to do business or to file a
general consent to service of process in any such states or jurisdictions; 
 (e) in the event of any underwritten public offering, enter
into and perform its obligations under an underwriting agreement, in usual and customary form, with the managing underwriter of such offering; 

(f) notify each Holder of Registrable Securities covered by such registration statement at any time when a prospectus relating thereto is
required to be delivered under the Act or the happening of any event as a result of which the prospectus included in such registration statement, as then in effect, includes an untrue statement of a material fact or omits to state a material fact
required to be stated therein or necessary to make the statements therein not misleading in the light of the circumstances then existing; 

  
 10 

 (g) cause all such Registrable Securities registered pursuant to this Agreement to be listed on
each securities exchange and/or quoted on each broker-dealer network on which similar securities issued by the Company are then listed and/or quoted; 

(h) provide a transfer agent and registrar for all Registrable Securities registered pursuant to this Agreement and a CUSIP number for all
such Registrable Securities, in each case not later than the effective date of such registration; 
 (i) use its best efforts to furnish, at
the request of any Holder requesting registration of Registrable Securities pursuant to this Section 1, on the date that such Registrable Securities are delivered to the underwriters for sale in connection with a registration pursuant to this
Section 1, if such securities are being sold through underwriters, or, if such securities are not being sold through underwriters, on the date that the registration statement with respect to such securities becomes effective, (x) an
opinion, dated such date, of the counsel representing the Company for the purposes of such registration, in form and substance as is customarily given to underwriters in an underwritten public offering, addressed to the underwriters, if any, and to
the Holders requesting registration of Registrable Securities and (y) a letter dated such date, from the independent certified public accountants of the Company, in form and substance as is customarily given by independent certified public
accountants to underwriters in an underwritten public offering, addressed to the underwriters, if any, and to the Holders requesting registration of Registrable Securities; 

(j) use all reasonable efforts to comply with the Sarbanes-Oxley Act of 2002 and all applicable federal and state securities laws, and all
rules and regulations of the Commission and each securities exchange or broker-dealer network on which similar securities issued by the Company are then listed and/or quoted; 

(k) make available to its security holders, as soon as reasonably practicable, an earnings statement covering the period of at least 12
months, but not more than 18 months, beginning with the first month after the effective date of the Registration Statement, which earnings statement shall satisfy the provisions of Section 11(a) of the Securities Act; and 

(l) if the registration is for an underwritten offering, cause management of the Company to participate in reasonable and customary roadshows
necessary to effect the disposition of the Registrable Securities. 
  

	 	1.6	Information from Holder 

 It shall be a condition precedent to the obligations of
the Company to take any action pursuant to this Section 1 with respect to the Registrable Securities of any selling Holder that such Holder shall furnish to the Company such information regarding itself, the Registrable Securities held by it,
and the intended method of disposition of such securities as shall be required to effect the registration of such Holder’s Registrable Securities. 
  

	 	1.7	Expenses of Registration 

 All fees and expenses (other than underwriting
discounts, commissions and stock transfer taxes) incurred in connection with registrations, filings or qualifications pursuant to Sections 1.2, 

  
 11 

 
1.3 and 1.4, including (without limitation) all registration, filing and qualification fees, printer’s and accounting fees, fees and disbursements of counsel for the Company and one
(1) counsel for the selling Holders, in an amount not to exceed $50,000, shall be borne by the Company, regardless of whether the Holders have sold any securities in such offering. Any expenses exceeding the limitations set forth in the
previous sentence shall be borne by the participating Holders pro rata based upon the number of Registrable Securities that were to be requested to be sold in such registration. Notwithstanding the foregoing, the Company shall not be required to pay
for any expenses of any registration proceeding begun pursuant to Section 1.2 or Section 1.4 if the registration request is subsequently withdrawn at the request of the Holders of a majority of the Registrable Securities to be registered
(in which case all participating Holders shall bear such expenses pro rata based upon the number of Registrable Securities that were to be requested in the withdrawn registration), unless the Holders of a majority of the Registrable Securities agree
to forfeit their right to one (1) demand registration pursuant to Section 1.2, or one (1) Form S-3 registration pursuant to Section 1.4 for the following twelve month period; provided, however, that if at the time
of such withdrawal, the Holders have learned of a material adverse change in the condition, business or prospects of the Company from that known to the Holders at the time of their request and have withdrawn the request with reasonable promptness
following disclosure by the Company of such material adverse change, then the Holders shall not be required to pay any of such expenses and shall retain their rights pursuant to Section 1.2. 

 

	 	1.8	Delay of Registration 

 No Holder shall have any right to obtain or seek an
injunction restraining or otherwise delaying any such registration as the result of any controversy that might arise with respect to the interpretation or implementation of this Section 1. 

 

	 	1.9	Indemnification 

 In the event any Registrable Securities are included in a
registration statement under this Section 1: 
 (a) To the extent permitted by law, the Company will indemnify and hold harmless each
Holder, the partners, members, former members, officers, directors, employees, stockholders, legal counsel and accountants of each Holder, any underwriter (as defined in the Act) for such Holder and each person, if any, who controls such Holder or
underwriter within the meaning of the Act or the 1934 Act, against any losses, claims, damages or liabilities (joint or several) to which they may become subject under the Act, the 1934 Act, any state securities laws or any rule or regulation
promulgated under the Act, insofar as such losses, claims, damages, or liabilities (or actions in respect thereof) arise out of or are based upon any of the following statements, omissions or violations (collectively a
“Violation”): (i) any untrue statement or alleged untrue statement of a material fact contained or incorporated by reference in such registration statement, offering circular or other document including any preliminary
or final prospectus contained therein, and any amendments, supplements or exhibits thereto, or in any state “blue sky” filing required in connection therewith, (ii) the omission or alleged omission to state therein a material fact
required to be stated therein, or necessary to make the statements therein not misleading, or (iii) any violation or alleged violation by the Company of the Act, the 1934 Act, any state securities laws or any rule or regulation promulgated
under the Act, the 1934 

  
 12 

 
Act or any state securities laws, and the Company will reimburse each such Holder and each of such Holder’s partners, members, former members, officers, directors, employees, stockholders,
legal counsel and accountants, underwriter, controlling person or other aforementioned person for any legal or other expenses reasonably incurred by them in connection with investigating or defending any such loss, claim, damage, liability or action
as such expenses are incurred, provided, however, that the indemnity agreement contained in this Section 1.9(a) shall not apply to amounts paid in settlement of any such loss, claim, damage, liability or action if such settlement
is effected without the consent of the Company (which consent shall not be unreasonably withheld), nor shall the Company be liable in any such case for any such loss, claim, damage, liability or action to the extent that it arises out of or is based
upon a Violation that occurs in reliance upon and in conformity with written information furnished expressly for use in connection with such registration by any such Holder, underwriter, controlling person or other aforementioned person. 

(b) To the extent permitted by law, each selling Holder will severally but not jointly indemnify and hold harmless the Company, each of its
directors, each of its officers who has signed the registration statement, each person, if any, who controls the Company within the meaning of the Act, legal counsel and accountants for the Company, any underwriter, any other Holder selling
securities in such registration statement and each of their partners, members, former members, officers and directors and any controlling person of any such underwriter or other Holder, against any losses, claims, damages or liabilities to which any
of the foregoing persons may become subject, under the Act, the 1934 Act, any state securities laws or any rule or regulation promulgated under the Act, insofar as such losses, claims, damages or liabilities (or actions in respect thereto) arise out
of or are based upon: (i) any untrue statement or alleged untrue statement of a material fact contained or incorporated by reference in such registration statement, offering circular or other document including any preliminary or final
prospectus contained therein, and any amendments, supplements or exhibits thereto, or in any state “blue sky” filing required in connection therewith, or (ii) the omission or alleged omission to state therein a material fact required
to be stated therein, or necessary to make the statements therein not misleading, in each case to the extent (and only to the extent) that such Violation occurs in reliance upon and in conformity with written information furnished by such Holder
expressly for use in connection with such registration, and each such Holder will reimburse any person intended to be indemnified pursuant to this Section l.9(b), for any legal or other expenses reasonably incurred by such person in connection
with investigating or defending any such loss, claim, damage, liability or action as such expenses are incurred, provided, however, that the indemnity agreement contained in this Section 1.9(b) shall not apply to amounts paid in
settlement of any such loss, claim, damage, liability or action if such settlement is effected without the consent of the Holder (which consent shall not be unreasonably withheld), and provided further that in no event shall any
indemnity under this Section l.9(b) exceed the net proceeds from the offering received by such Holder. 
 (c) Promptly after receipt by
an indemnified party under this Section 1.9 of notice of the commencement of any action (including any governmental action), such indemnified party will, if a claim in respect thereof is to be made against any indemnifying party under this
Section 1.9, deliver to the indemnifying party a written notice of the commencement thereof and the indemnifying party shall have the right to participate in, and, to the extent the indemnifying party so desires, jointly with any other
indemnifying party similarly noticed, to 

  
 13 

 
assume the defense thereof with counsel mutually satisfactory to the parties, provided, however, that an indemnified party (together with all other indemnified parties that may be
represented without conflict by one counsel) shall have the right to retain one separate counsel, with the fees and expenses to be paid by the indemnifying party, if representation of such indemnified party by the counsel retained by the
indemnifying party would be inappropriate due to actual or potential differing interests between such indemnified party and any other party represented by such counsel in such proceeding. The failure to deliver written notice to the indemnifying
party within a reasonable time of the commencement of any such action, unless prejudicial to its ability to defend such action, shall not relieve such indemnifying party of any liability to the indemnified party under this Section 1.9, and the
omission so to deliver written notice to the indemnifying party will not relieve it of any liability that it may have to any indemnified party otherwise than under this Section 1.9. 

(d) If the indemnification provided for in this Section 1.9 is held by a court of competent jurisdiction to be unavailable to an
indemnified party with respect to any loss, liability, claim, damage or expense referred to herein, then the indemnifying party, in lieu of indemnifying such indemnified party hereunder, shall contribute to the amount paid or payable by such
indemnified party as a result of such loss, liability, claim, damage or expense in such proportion as is appropriate to reflect the relative fault of the indemnifying party on the one hand and of the indemnified party on the other in connection with
the statements or omissions that resulted in such loss, liability, claim, damage or expense, as well as any other relevant equitable considerations, provided, however, that no contribution from any Holder, when combined with any
amounts paid by such Holder pursuant to Section 1.9(b), shall exceed the net proceeds from the offering received by such Holder. The relative fault of the indemnifying party and of the indemnified party shall be determined by reference to,
among other things, whether the untrue or alleged untrue statement of a material fact or the omission to state a material fact relates to information supplied by the indemnifying party or by the indemnified party and the parties’ relative
intent, knowledge, access to information, and opportunity to correct or prevent such statement or omission. 
 (e) Notwithstanding the
foregoing, to the extent that the provisions on indemnification and contribution contained in the underwriting agreement entered into in connection with the underwritten public offering are in conflict with the foregoing provisions, the provisions
in the underwriting agreement shall control, provided, however, that failure of an underwriting agreement to cover a term provided in these provisions shall not be deemed a conflict. 

(f) The obligations of the Company and Holders under this Section 1.9 shall survive the completion of any offering of Registrable
Securities in a registration statement and, with respect to liability arising from an offering to which this Section 1.9 would apply that is covered by a registration filed before termination of this Agreement, such termination. No indemnifying
party, in the defense of any such claim or litigation, shall, except with the consent of each indemnified party, consent to entry of any judgment or enter into any settlement which does not include as an unconditional term thereof the giving by the
claimant or plaintiff to such indemnified party of a release from all liability in respect to such claim or litigation. 

  
 14 

	 	1.10	Reports Under the 1934 Act 

 With a view to making available to the Holders the
benefits of Rule 144 promulgated under the Act and any other rule or regulation of the SEC that may at any time permit a Holder to sell securities of the Company to the public without registration or pursuant to a registration on Form S-3, the
Company agrees to: 
 (a) make and keep public information available, as those terms are understood and defined in SEC Rule 144 or any
successor rule promulgated under the Act (“Rule 144”), at all times after the effective date of the initial public offering of the Company’s equity securities, 

(b) file with the SEC in a timely manner all reports and other documents required of the Company under the Act and the 1934 Act; and 

(c) furnish to any Holder, so long as the Holder owns any Registrable Securities, forthwith upon request (i) a written statement by the
Company that it has complied with the reporting requirements of Rule 144 (at any time after ninety (90) days after the effective date of the first registration statement filed by the Company), the Act and the 1934 Act (at any time after it has
become subject to such reporting requirements), or that it qualifies as a registrant whose securities may be resold pursuant to Form S-3 (at any time after it so qualifies), (ii) a copy of the most recent annual or quarterly report of the
Company and such other reports and documents so filed by the Company, and (iii) such other information as may be reasonably requested in availing any Holder of any rule or regulation of the SEC that permits the selling of any such securities
without registration or pursuant to such form. 
  

	 	1.11	Assignment of Registration Rights 

 The rights to cause the Company to register
Registrable Securities pursuant to this Section 1 may be assigned (but only with all related obligations) by a Holder to a transferee or assignee of such securities that (i) is a partner, limited partner or retired partner of a Holder that
is a partnership, or is a member or retired member of any Holder that is a limited liability company (in each case provided that such constituent partners, members, and other persons agree to act through a single representative in connection
with the rights granted hereunder), (ii) is a spouse, sibling, lineal descendant or ancestor of a Holder, or any trust established for the benefit of a Holder or any spouse, sibling, lineal descendant or ancestor of a Holder, (iii) is an
affiliate of the Holder, or (iv) after such assignment or transfer, holds at least 100,000 shares of Registrable Securities (subject to appropriate adjustment for stock splits, stock dividends, combinations and other recapitalizations) (or such
lesser amount if the Holder is transferring all Registrable Securities held by the Holder), provided: (a) the Company is, within a reasonable time after such transfer, furnished with written notice of the name and address of such transferee or
assignee and the securities with respect to which such registration rights are being assigned, and (b) such transferee or assignee agrees in writing to be bound by and subject to the terms and conditions of this Agreement, including without
limitation the provisions of Section 1.13 below. 
  

	 	1.12	Limitations on Subsequent Registration Rights 

 From and after the date of this
Agreement, the Company shall not, without the prior written consent of the Holders of at least sixty-six and two/thirds percent (66-2/3%) of the 

  
 15 

 
Registrable Securities, enter into any agreement with any holder or prospective holder of any securities of the Company that would allow such holder or prospective holder: (a) to include
such securities in any registration filed under Section 1.2, Section 1.3 or Section 1.4 hereof, unless under the terms of such agreement, such holder or prospective holder may include such securities in any such registration only to
the extent that the inclusion of such securities will not reduce the amount of the Registrable Securities of the Holders that are included, (b) to demand registration of their securities on a junior or pari passu basis with the rights of the
Holders hereunder, or (c) to exercise other registration rights that are pari passu to those granted to the Holders hereunder; provided, however, that the Company shall not, without the prior written consent of the Holders of at
least ninety percent (90%) of the Registrable Securities, enter into any agreement with any holder or prospective holder of any securities of the Company that would grant such holder registration rights that are senior to those granted to the
Holders hereunder. 
  

	 	1.13	Market Stand-off Agreement 

 Each Holder hereby agrees that, upon the request of
the managing underwriters, it will not, without the prior written consent of the managing underwriters, during the period commencing on the date of the final prospectus relating to the Company’s public offering and ending on the date specified
by the Company and the managing underwriters (such period not to exceed one hundred eighty (180) days if such public offering is the Initial Offering or ninety (90) days if such public offering is not the Initial Offering, in either case,
following the effective date of the registration statement for such offering, or such longer period as the underwriters or the Company shall request in order to facilitate compliance with NASD Rule 2711 or NYSE Member Rule 472 or any successor or
similar rule or regulation, if so required by the underwriters of such offering), (i) offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to
purchase, lend, or otherwise transfer or dispose of, directly or indirectly, any shares of Common Stock beneficially owned (as such term is used in Rule 13d-3 of the 1934 Act), by the Holder or any other securities so owned convertible into or
exercisable or exchangeable for Common Stock or (ii) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of the Common Stock, whether any such transaction
described in clause (i) or (ii) above is to be settled by delivery of Common Stock or such other securities, in cash or otherwise. The foregoing provisions of this Section 1.13 shall not apply to the sale of any shares to an
underwriter pursuant to an underwriting agreement. The underwriters in connection with the Initial Offering are intended third party beneficiaries of this Section 1.13 and shall have the right, power and authority to enforce the provisions
hereof as though they were a party hereto. In order to enforce the foregoing covenant, the Company may impose stop-transfer instructions with respect to the shares or securities of each Holder and every other person subject to the foregoing
restriction until the end of such period. Each Holder agrees to execute a market standoff agreement with said underwriters in customary form consistent with the provisions of this Section 1.13. 

 

	 	1.14	Termination of Registration Rights 

 No Holder (other than the General Atlantic
Stockholders and the TPG Stockholders) shall be entitled to exercise any right provided for in this Section 1 after the earliest of, (a) five (5)

  
 16 

 
years following the consummation of the Initial Offering, or (b) as to any Holder, such time at which all Registrable Securities held by such Holder (and any affiliate of the Holder with
whom such Holder must aggregate its sales under Rule 144) can be sold in any three (3) month period without registration in compliance with Rule 144 of the Act. Following the consummation of the Initial Offering, the General Atlantic
Stockholders shall not be entitled to exercise the rights provided for in this Section 1 after the date on which the General Atlantic Stockholders (in the aggregate) cease to be an affiliate (as defined in Rule 405 promulgated under the 1934
Act) of the Company and hold, in the aggregate, less than five percent (5%) of the outstanding shares of Class A Common. Following the consummation of the Initial Offering, the TPG Stockholders shall not be entitled to exercise the rights
provided for in this Section 1 after the date on which the TPG Stockholders (in the aggregate) cease to hold an amount of Registrable Securities that is, in the aggregate, less than a majority of the amount of Registrable Securities it
originally purchased. 
  

	 	1.15	Definitions After Initial Offering  

 If the Certificate of Incorporation to be in
effect upon the closing of the Initial Offering (the “Post-IPO Certificate”) provides for the conversion of all shares of Common Stock into a new class of Common Stock to be called “Class B Common Stock” and
authorizes a new class of Common Stock to be called “Class A Common Stock,” then effective as of the closing of the Initial Offering, all references to “Common Stock,” “Class A Common” and “Class B Common” in
this Agreement shall be deemed references to the Class B Common Stock authorized by the Post-IPO Certificate and any Class A Common Stock (as defined in the Post-IPO Certificate) issued upon the conversion thereof after the closing of the
Initial Offering, collectively. Wherever necessary, all other terms of this Agreement will be construed to be consistent with the terms of the foregoing; provided, however, that notwithstanding anything to the contrary, all references to
“Common Stock” in Section 1.2, Section 1.3 and Section 1.13 shall be deemed references to the Class A Common Stock and Class B Common Stock authorized by the Post-IPO Certificate, collectively; provided further,
that notwithstanding anything to the contrary, the reference to “Class A Common” in Section 1.14 shall be deemed a reference to the Class A Common Stock and Class B Common Stock authorized by the Post-IPO Certificate,
collectively. 
  

	2.	Covenants 

 The Company hereby covenants to each of the Series A Holders, the
Series B Holders, the Series C Holders, the Series D Holders, the Series D-1 Holders, the Series D-2 Holders, the Series E Holders, the Series E-1 Holders and the Series F Holders as follows: 
  

	 	2.1	Delivery of Financial Statements 

 The Company shall deliver to each Series A
Holder, Series B Holder, Series C Holder, Series D Holder, Series D-1 Holder, Series D-2 Holder, Series E Holder, Series F Holder, or
transferee who holds at least 500,000 shares of Registrable Securities (as adjusted for splits, dividends, combinations and other recapitalizations), DST Global III, L.P. (together with its affiliates, “DST”),
Mitsui & Co. (USA), Inc. (together with its affiliates, “Mitsui”), Telefonica Digital Venture Capital, S.L. (together with its affiliates, “Telefonica”), Telstra Ventures Pty Ltd (together
with its affiliates, “Telstra”) and Macnica Investment Partners (together with its 

  
 17 

 
affiliates, “Macnica”) for so long as each of DST, Mitsui, Telefonica, Telstra and Macnica hold at least 100,000 shares of
Series E-1 Preferred (in each case, as adjusted for splits, dividends, combinations and other recapitalizations) (each Holder or other person referenced in this paragraph, a “Major
Investor”): 
 (a) as soon as practicable, but in any event within ninety (90) days after the end of each fiscal year of
the Company, an income statement for such fiscal year, a balance sheet of the Company and statement of stockholders’ equity as of the end of such year, and a statement of cash flows for such year, such year-end financial reports to be in
reasonable detail, prepared in accordance with generally accepted accounting principles (“GAAP”) and certified by independent public accountants of national standing selected by the Company; provided that the holders
of a majority of the Registrable Securities may waive the requirement to have such financial statements audited and certified by independent public accountants. 

(b) as soon as practicable, but in any event within forty-five (45) days of the end of each calendar quarter and within thirty
(30) days of the end of each month, an income statement and statement of cash flows and balance sheet for and as of the end of such period, in reasonable detail, each of the foregoing income statement, statement of cash flows and balance sheet
also to set forth in comparative form the budgeted amounts for such period and the corresponding figures for the period in the prior fiscal year, to be in reasonable detail and prepared in accordance with GAAP; 

(c) as soon as practicable, but in any event no more than fifteen (15) days after the end of each fiscal year, a budget and business plan
for the next fiscal year, prepared on a monthly basis (including balance sheets, income statements and statements of cash flows for such months); and 

(d) other information as reasonably requested by any Major Investor. 

 

	 	2.2	Inspection 

 The Company shall permit each Major Investor, at such Major
Investor’s expense, to visit and inspect the Company’s properties, to examine its books of account and records and to discuss the Company’s affairs, finances and accounts with its executive officers, all at such reasonable times as
may be requested by the Major Investor; provided, however, that the Company shall not be obligated pursuant to this Section 2.2 to provide access to any information that it reasonably considers to be a trade secret or similar
confidential information if, in consultation with legal counsel, the Company determines that providing such access would compromise the Company’s rights with respect to such information, unless such Major Investor delivers a confidentiality and
non-disclosure agreement in the form and substance reasonably satisfactory to the Company’s legal counsel. 
  

	 	2.3	Right of First Offer 

 (a) Subject to the terms and conditions specified in this
Section 2.3, if the Company proposes to issue Additional Shares of Common Stock (as defined in Section 4(d)(i)(B)(4) of Division (B) of Article IV of the Company’s Amended and Restated Certificate of Incorporation (as may be
amended, the “Restated Charter”)), other than as currently contemplated in the 

  
 18 

 
Purchase Agreement, it shall in any case provide each Major Investor, and each Series E-1 Holder who holds at least 500,000 shares of Registrable
Securities (as adjusted for splits, dividends, combinations and other recapitalizations) (each, an “Offeree”), with a written notice (the “Issuance Notice”) stating (i) its bona fide intention to
offer such Additional Shares of Common Stock, (ii) the number of such Additional Shares of Common Stock to be offered, and (iii) the price and terms upon which it proposes to offer such Additional Shares of Common Stock. By written
notification received by the Company (an “Election Notice”), within fifteen (15) calendar days after receipt of the Issuance Notice, each Offeree may elect to purchase or obtain, at the price and on the terms specified
in the Issuance Notice, up to that portion of such Additional Shares of Common Stock (such holder’s “Pro-Rata Portion”) that equals the proportion that the number of shares of
Registrable Securities then held by such Offeree bears to the total number of shares of Common Stock of the Company then outstanding (including the Common Stock issuable upon conversion of all outstanding shares of Preferred Stock, upon conversion
of all other outstanding convertible securities, and upon exercise of all outstanding options (and assuming conversion of convertible securities issuable upon exercise of options)). Additionally, in connection with any such issuance, within fifteen
(15) calendar days after receipt of the Issuance Notice, each of the General Atlantic Stockholders and TPG Stockholders may elect to purchase or obtain, at the price and on the terms specified in the Issuance Notice, the number of shares of
Additional Common Stock proposed to be sold by the Company in such issuance (the “Additional GA/TPG Shares”) equal to the total number of Additional Shares of Common Stock proposed to be sold by the Company in such offering
less the number of shares equal to the aggregate Pro Rata Portion of the Additional Shares of Common Stock that all Offerees are entitled to purchase pursuant to this Section 2.3(a) in connection with such offering. Any election to
purchase such Additional GA/TPG Shares shall be allocated among the electing General Atlantic Stockholders and TPG Stockholders on a pro rata basis, in each case, based on the aggregate amount of Registrable Securities then held by such electing
holder as compared to the aggregate amount of Registrable Securities then held by all such electing holders. 
 (b) In the event that
(i) an Offeree fails to give an Election Notice within the prescribed period, or otherwise fails to purchase its Pro-Rata Portion of such Additional Shares of Common Stock (not including, in the case of the General Atlantic Stockholders and TPG
Stockholders, the Additional GA/TPG Shares), the Company shall promptly inform in writing each Offeree that has elected to purchase its full Pro-Rata Portion (a “Fully Exercising Investor”) of any other Offeree’s failure
to do so. During the ten (10) day period commencing after the delivery of such supplemental notice, each Fully Exercising Investor shall be entitled to obtain its pro-rata portion of the remaining Additional Shares of Common Stock not purchased
by the other Offerees (such right does not include the right to purchase a Pro Rata Portion of the Additional GA/TPG Shares not purchased by the General Atlantic Stockholders or TPG Stockholders). For the purposes of this Section 2.3, a Fully
Exercising Investor’s pro rata portion shall equal the proportion that the number of shares of Registrable Securities then held by a Fully Exercising Investor bears to the total number of shares of Registrable Securities then held by all Fully
Exercising Investors. If not all Fully Exercising Investors choose to purchase all the shares available to them, the other Fully Exercising Investors shall be offered those shares on a similar pro rata basis based upon the ownership of Registrable
Securities of all Fully Exercising Investors who continue to wish to purchase additional shares, until all of the shares not purchased by Offerees (other than the Additional GA/TPG Shares which shall only be available

  
 19 

 
to be purchased by the General Atlantic Stockholders and TPG Stockholders) have been allocated to Offerees or all Offerees no longer wish to purchase additional shares. An Offeree shall be
entitled to apportion the right of first offer hereby granted it among itself and its partners, members and affiliates in such proportions as it deems appropriate. 

(c) If all Additional Shares of Common Stock that Offerees and/or the General Atlantic Stockholders and/or the TPG Stockholders, as the case
may be, are entitled to purchase or obtain pursuant to Sections 2.3(a) and (b) are not elected to be purchased or obtained as provided in Sections 2.3(a) and (b) hereof, the Company may, during the one hundred twenty (120) day period
following the expiration of the period provided in Sections 2.3(a) and (b) hereof, as the case may be, offer the remaining unsubscribed portion of such Additional Shares of Common Stock to any person or persons at a price not less than, and
upon terms no more favorable to the offeree than those specified in the Issuance Notice. If the Company does not enter into an agreement for the sale of the Additional Shares of Common Stock within such period, or if such agreement is not
consummated within one hundred twenty (120) days of the execution thereof, the right provided hereunder shall be deemed to be revived and such Additional Shares of Common Stock shall not be offered unless first reoffered to the Offerees in
accordance herewith. 
 (d) The right of first offer in this Section 2.3 shall not be applicable to the issuance of securities excluded
from the definition of Additional Shares of Common Stock in the Restated Certificate. 
 (e) The right of first offer in this
Section 2.3 shall not be applicable with respect to any Offeree with regard to any issue of Additional Shares of Common Stock, if (i) at the time of such issue of Additional Shares of Common Stock, such Offeree is not an accredited
investor, and (ii) such issue of Additional Shares of Common Stock is otherwise being offered only to accredited investors. 
 (f) The
Company will not grant any right of first offer to any subsequent purchasers of the Company’s equity securities other than by having them become parties hereto in accordance with the amendment provisions hereof. 

(g) The rights of first refusal of each Offeree under this Section 2 may be assigned to the same parties, subject to the same
restrictions as any transfer of registration rights pursuant to Section 1.11. 
 (h) In the event that the Right of First Offer in this
Section 2.3 is waived pursuant to Section 3.7 hereof with respect to an issuance of Additional Shares of Common Stock by the Company, and any Offeree that consented to such waiver pursuant to Section 3.7 purchases any Additional
Shares of Common Stock sold in such offering (a “Waiving Investor”), each Offeree that is not a Waiving Investor shall be entitled to purchase its Adjusted Pro-Rata Share of the Additional Shares of Common Stock sold in such
offering upon the terms and conditions set forth in Sections 2.3(a) and 2.3(b). For purposes of this Section 2.3(h), an Offeree’s “Adjusted Pro-Rata Share” of the Additional Shares of Common Stock subject to the
waiver described herein shall be equal to (i) such Offeree’s Pro-Rata Portion of the Additional Shares of Common Stock sold in such offering multiplied by (ii) the highest percentage (up to

  
 20 

 
100%) of any Waiving Investor’s Pro-Rata Portion that such Waiving Investor purchases in such offering. For example, if only one Waiving Investor purchases Additional Shares of Common Stock
in such offering and it purchases 50% of its Pro-Rata Portion in such offering, each Offeree’s Adjusted Pro-Rata Share shall be equal to 50% of its Pro-Rata Portion. For another example, if one Waiving Investor purchases 60% of its Pro-Rata
Portion in such offering and another Waiving Investor purchases 110% of its Pro-Rata Portion in such offering, each Offeree’s Adjusted Pro-Rata Share shall be equal to 100% of its Pro-Rata Portion. 

(i) Notwithstanding the foregoing, to the extent such Offeree is a Company Covered Person or will become a Company Covered Person as a result
of a particular acquisition of Additional Shares of Common Stock or Additional GA/TPG Shares contemplated hereby, such Offeree will not have a right of first offer under this Section 2.3 with respect to the offering of such Additional Shares of
Common Stock or Additional GA/TPG Shares if, and for so long as, the Offeree, any of its directors, executive officers, general partners or managing members or any person that would be deemed a beneficial owner of the securities of the Company held
by the Offeree (in accordance with Rule 506(d) of the Act) is subject to any “bad actor” disqualification described in Rule 506(d)(1)(i) through (viii) under the Act (a “Bad Actor Disqualification”),
except as set forth in Rule 506(d)(2) or (d)(3) under the Act. Each party to this Agreement will promptly notify each other party to this Agreement in writing if it or, to its knowledge, any person specified in Rule 506(d)(1) under the Act
becomes subject to any Bad Actor Disqualification. To the extent any Offeree is prohibited from participating in an offering pursuant to this Section 2.3(i), such Offeree will still be permitted to assign its rights to participate in such
offering to any affiliate of such Offeree that is not subject to a Bad Actor Disqualification. For purposes of this Section 2.3(i), a “Company Covered Person” means, with respect to the Company as an “issuer”
for purposes of Rule 506 promulgated under the Securities Act, any person or entity listed in the first paragraph of Rule 506(d)(1). 
  

	 	2.4	Observer Rights 

 The Company shall grant to one designee of each of Draper Fisher
Jurvetson, U.S. Venture Partners, Scale Venture Partners, Meritech Capital Partners, Emergence Capital Partners, Bessemer Venture Partners, New Enterprise Associates, General Atlantic Partners 90, L.P., the Coatue Stockholders and, for so long as
the TPG Stockholders hold at least a majority of the Series F Preferred purchased by them pursuant to the Purchase Agreement, the TPG Stockholders (each, an “Observer Rights Holder”) visiting rights to attend all meetings of
the Board of Directors in a nonvoting observer capacity (each, an “Observer”) and in connection therewith, the Company shall give such Observers copies of all notices, minutes, consents and other materials, financial or
otherwise that the Company provides to its directors (including but not limited to full reports of independent third-party valuation firms for purposes of compliance with Section 409A of the Internal Revenue Code); provided,
however, that such Observer shall agree to hold in confidence and trust all information so provided; and, provided further, that the Company reserves the right to withhold any information and to exclude such visitors from any
meeting or portion thereof if, in the opinion of counsel to the Company, such exclusion is reasonably necessary to preserve the attorney-client privilege, or is necessary to protect highly confidential proprietary information. 

  
 21 

	 	2.5	Expenses 

 The Company shall pay the reasonable out-of-pocket expenses incurred by non-employee directors and one (1) Observer of each of Draper Fisher Jurvetson, U.S. Venture Partners, Scale Venture Partners,
Meritech Capital Partners, Emergence Capital Partners, Bessemer Venture Partners, New Enterprise Associates, General Atlantic Partners 90, L.P., the Coatue Stockholders and the TPG Stockholders, in connection with their attendance at Board of
Directors meetings, committee meetings of the Board of Directors, or other Company-authorized business. 
  

	 	2.6	Board Committees; Executive Compensation and Related Party Transactions 

 The
Company will maintain a Compensation Committee (the “Committee”) comprised of all non-employee board members. All compensation of executives of the Company (whether consisting of cash, equity or otherwise) shall require the
approval of the Compensation Committee. For purposes of this Section 2.6, “executives” shall mean all senior managers of vice-president or higher rank. The member of the Board of Directors designated by Scale Venture Partners and the
member of the Board of Directors designated by General Atlantic Partners 90, L.P. shall each have the right to be a member of all committees of the Board of Directors or, if not a member, to attend all such committee meetings; the member of the
Board of Directors designated by TPG Bogota Holdings, L.P. or the Series F Preferred shall have the right to be a member of all committees of the Board of Directors or, if not a member, to attend all such committee meetings. 

 

	 	2.7	Stock Option Vesting 

 Except as expressly approved by the Board of Directors,
options issued pursuant to the Company’s 2006 Stock Incentive Plan and the Company’s 2011 Equity Incentive Plan, stock grants or other equity grants shall be granted with a four year vesting schedule, with 25% of the securities vesting on
the first anniversary of the vesting commencement date and the remainder vesting at the rate of 1/48 of the total grant each month. 
  

	 	2.8	Proprietary Information and Inventions Agreement 

 Each officer, employee and
consultant of the Company shall enter into the Company’s standard proprietary information and inventions agreement. 
  

	 	2.9	Drag-Along Rights 

 (a) Anything contained
herein to the contrary notwithstanding, if at any time (1) the Board of Directors of the Company, and (2) the holders of at least ninety percent (90%) of the outstanding shares of Preferred Stock, voting together as a single class,
shall approve a bona fide proposal from a third party with respect to a sale of the Company whether by merger, asset or stock sale or otherwise, for a specified price payable in cash or otherwise and on specified terms and conditions (a
“Sale Proposal”), then the Company shall deliver a notice (a “Required Sale Notice”) with respect to such Sale Proposal to all Investors and the Founders (together, the
“Stockholders”) stating that the Company proposes to effect the Sale Proposal and providing the identity of the persons involved in such Sale Proposal and the terms thereof. Each

  
 22 

 
such Stockholder and each Stockholder’s transferee, upon receipt of a Required Sale Notice, shall be obligated, which obligation shall be enforceable by the Company, to sell its stock and
participate in the transaction (a “Required Sale”) contemplated by the Sale Proposal, vote its shares of stock in favor of such Sale Proposal at any meeting of Stockholders called to vote on or approve such Sale Proposal, or
in any written consent of Stockholders or similar instrument, and otherwise to take any necessary action to enable the Company and the Stockholders to consummate such Required Sale. Any such Required Sale Notice may be rescinded by the Company by
delivering written notice thereof to all the Stockholders. 
 (b) The obligations of the Stockholders pursuant to this Section 2.9 are
subject to the satisfaction of the following conditions: 
 (1) upon the consummation of the Required Sale (or as promptly thereafter as
practical in the case of certain options to purchase stock, pursuant to outstanding option agreements), all of the Stockholders shall receive the proportion of the aggregate consideration from such Required Sale in accordance with the preferences
and other rights set forth in Section 2 of Division B of Article IV of the Restated Charter; 
 (2) no Stockholder shall be obligated
to make any out-of-pocket expenditure prior to the consummation of the Required Sale and no Stockholder shall be obliged to pay more than such Stockholder’s pro rata share (based upon the amount of consideration received) of reasonable expenses
incurred in connection with a consummated Required Sale to the extent such costs are incurred for the benefit of all Stockholders and are not otherwise paid by the Company or the acquiring party (costs incurred by or on behalf of a Stockholder for
such Stockholder’s sole benefit will not be considered costs of the transaction hereunder), provided that a Stockholder’s liability for such expenses shall be capped at the total purchase price received by such Stockholder for such
Stockholder’s shares of stock (including the exercise price thereof); 
 (3) in the event that the Stockholders are required to
provide any indemnification in connection with the Required Sale (other than indemnification concerning each Stockholder’s valid ownership of such Stockholder’s shares of stock, free of all liens and encumbrances (other than those arising
under applicable securities laws), and each Stockholder’s authority, power, and right to enter into and consummate such purchase or merger agreement without violating any other agreement), then each Stockholder shall not be liable for more than
such Stockholder’s pro rata share (based upon the amount of consideration received) of such indemnity and the liability of each Stockholder shall not exceed the total purchase price received by such Stockholder for such Stockholder’s
shares of stock (absent fraud by such Stockholder); and 
 (4) prior notice of a Required Sale shall be provided to the Stockholders. 

  
 23 

 (c) The obligations of Intel Capital Corporation and Telstra pursuant to this Section 2.9
are further subject to the satisfaction of the following conditions: 
 (1) The only representations, warranties or covenants that Intel
Capital Corporation and Telstra shall be required to make in connection with a Required Sale are representations and warranties with respect to (A) ability to execute, deliver and perform any acquisition agreement; (B) its own ownership of
the Company’s securities to be sold by it; (C) its ability to convey title thereto free and clear of liens, encumbrances or adverse claims; and (D) reasonable covenants regarding confidentiality, publicity and similar matters. 

(2) Other Agreements. Intel Capital Corporation and Telstra shall not be required to amend, extend or terminate any contractual or other
relationship with the Company, the acquirer or their respective affiliates. 
 (3) Covenant Not to Compete. Intel Capital Corporation and
Telstra shall not be required to agree to any covenant not to compete or covenant not to solicit customers, employees or suppliers of any party to the Required Sale. 

(d) The obligations of the TPG Stockholders pursuant to this Section 2.9 are further subject to the satisfaction of the following
conditions: 
 (1) The only representations, warranties or covenants that TPG Stockholders shall be required to make in connection with a
Required Sale are representations and warranties with respect to (A) ability to execute, deliver and perform any acquisition agreement; (B) its own ownership of the Company’s securities to be sold by it; (C) its ability to convey
title thereto free and clear of liens, encumbrances or adverse claims; and (D) reasonable covenants regarding confidentiality, publicity and similar matters. 

(2) Covenant Not to Compete. TPG Stockholders shall not be required to agree to any covenant not to compete or covenant not to solicit
customers, employees or suppliers of any party to the Required Sale. 
  

	 	2.10	Legal Fees and Expenses 

 The Company shall reimburse the reasonable fees and
expenses of one (1) special counsel to the holders of Preferred Stock in an amount not to exceed $5,000.00 to review closing documents on their behalf in each future financing transaction in which net proceeds to the Company total at least
$1,000,000, and the Company shall reimburse the reasonable fees and expenses of one (1) special counsel to the holders of Preferred Stock in an amount not to exceed $30,000.00 in connection with a Required Sale. 

 

	 	2.11	Directors’ Liability and Indemnification.  

 The Company’s
Certificate of Incorporation and Bylaws shall provide (a) for elimination of the liability of director to the maximum extent permitted by law and (b) for indemnification of directors for acts on behalf of the Company to the maximum extent
permitted by law. In addition, the Company shall enter into and use its best efforts to at all times maintain indemnification agreements with each of its directors to indemnify such directors to the maximum extent permissible under applicable law
and in a form reasonably acceptable to the directors and the Major Investors. 

  
 24 

	 	2.12	Lock-Up Agreement. 

 The Company agrees that, until the time of the Initial
Offering, in the event that the Company enters into an agreement to issue shares of its capital stock (or securities convertible or exercisable into shares of capital stock), the Company agrees to include, as a condition to entering into such
agreement, a market standoff or “lockup” language substantially the same as Section 1.13. 
  

	 	2.13	Voting Agreement. 

 The Company agrees that, until the time of the Initial
Offering, in the event that the Company enters into an agreement to issue shares of its capital stock, following which such holder of common stock shall hold securities of the Company constituting one percent (1%) or more of the Company’s
then outstanding capital stock (treating for this purpose all shares of Common Stock issuable upon exercise of or conversion of outstanding options, warrants or convertible securities, as if exercised and/or converted or exchanged), then, the
Company shall cause such holder, as a condition precedent to entering into such agreement, to become a party to that certain Seventh Amended and Restated Voting Agreement, by and between the Company, the Founders and the Investors (as such terms are
defined therein), of even date herewith, as may be amended from time to time. 
  

	 	2.14	Assignment of Right of First Refusal.  

 In the event the Company elects
not to exercise in full any right of first refusal or right of first offer the Company may have on a proposed transfer of any of the Company’s outstanding shares of capital stock pursuant to the Company’s charter documents, by contract or
otherwise, the Company shall assign such right of first refusal or right of first offer with respect to any shares not acquired by the Company to each Offeree. Such assignment shall be made not less than fifteen (15) days prior to the date of
the termination of the Company’s first refusal or first offer right. Each Offeree shall have a right to purchase its pro rata share of the capital stock proposed to be transferred. Each Offeree’s pro rata share is equal to
the product obtained by multiplying (a) the aggregate number of shares proposed to be transferred by (ii) a fraction, the numerator of which is the number of shares of Preferred Stock of which such Offeree is deemed to be a holder
immediately prior to the proposed transfer and the denominator of which is the total number of shares of Preferred Stock owned by all Offerees at the time of such proposed transfer. 

 

	 	2.15	Termination of Covenants 

 The covenants set forth in Section 2, other than
the provisions of Section 2.11, shall terminate and be of no further force or effect (a) upon the consummation of the Company’s Initial Offering, (b) at such time as the Company becomes subject to the reporting provisions of the
Securities Exchange Act of 1934, as amended, or (c) upon the consummation of a Liquidation Event or a Deemed Liquidation (in each case, as defined in the Restated Charter). 

  
 25 

	3.	Miscellaneous 

  

	 	3.1	Legend 

 Each certificate evidencing any of the Registrable Securities shall bear
a legend substantially as follows: 
 “THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO THE TERMS AND CONDITIONS OF A
CERTAIN INVESTORS’ RIGHTS AGREEMENT BETWEEN THE COMPANY AND THE STOCKHOLDER, AND MAY NOT BE SOLD, TRANSFERRED OR ENCUMBERED EXCEPT IN ACCORDANCE WITH THE TERMS AND PROVISIONS OF SAID AGREEMENT, A COPY OF WHICH IS ON FILE AT THE PRINCIPAL
EXECUTIVE OFFICE OF THE COMPANY AND WILL BE FURNISHED TO THE HOLDER OF THIS CERTIFICATE UPON REQUEST AND WITHOUT CHARGE.” 
  

	 	3.2	Successors and Assigns 

 Except as otherwise provided herein, the terms and
conditions of this Agreement shall inure to the benefit of and be binding upon the respective successors and assigns of the parties (including transferees of any shares of Registrable Securities). Nothing in this Agreement, express or implied, is
intended to confer upon any party other than the parties hereto or their respective successors and assigns any rights, remedies, obligations, or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement. 

 

	 	3.3	Governing Law 

 This Agreement and all acts and transactions pursuant hereto and
the rights and obligations of the parties hereto shall be governed by and construed under the laws of the State of Delaware, as applied to agreements among Delaware residents entered into and to be performed entirely within Delaware without giving
effect to principles of conflicts of law. 
  

	 	3.4	Counterparts 

 This Agreement may be executed in two or more counterparts, each of
which shall be deemed an original and all of which together shall constitute one and the same instrument. 
  

	 	3.5	Titles and Subtitles 

 The titles and subtitles used in this Agreement are used
for convenience only and are not to be considered in construing or interpreting this Agreement. 
  

	 	3.6	Notices 

 Unless otherwise provided, any notice under this Agreement shall be
given in writing and shall be deemed effectively delivered (a) upon personal delivery to the party to be notified, 

  
 26 

 
(b) when sent by electronic mail or facsimile if sent during normal business hours of the recipient; if not, then on the next business day, (c) five (5) days after having been sent
by registered or certified mail, return receipt requested, postage prepaid, or (d) one (1) business day after deposit with a reputable overnight courier, prepaid for overnight delivery and addressed to the party to be notified at the
address indicated for such party on the exhibits hereto, or at such other address as such party may designate by ten (10) days advance written notice to the other party given in the foregoing manner. 

 

	 	3.7	Entire Agreement; Amendments and Waivers 

 This Agreement (including the exhibits
hereto) and the documents referred to herein constitute the full and entire understanding and agreement among the parties with regard to the subjects hereof and thereof, and no party shall be liable or bound to any other party in any manner by any
warranties, representations, or covenants, except as specifically set forth herein or therein. Without limiting the foregoing, this Agreement amends and restates the Existing Investors’ Rights Agreement in its entirety. Except as set forth
herein, any term of this Agreement may be amended and the observance of any term of this Agreement may be waived (either generally or in a particular instance and either retroactively or prospectively), only with the written consent of the Company
and the holders of a majority of the Registrable Securities; provided, however, that (i) any amendment of Section 2.1 that would result in DST, Mitsui, Telefonica, Telstra or Macnica not having the status of a Major Investor
as a result of such amendment, or (ii) any waiver of Section 2.1 that only applies to DST, Mitsui, Telefonica, Telstra or Macnica, shall require the written consent of DST, Mitsui, Telefonica, Telstra or Macnica, as the case may be;
provided, further, that any amendment or waiver of Section 2.3 shall require the written consent of the Company and the holders of a majority of Registrable Securities held by the Major Investors and shall be subject to the
provisions of Section 2.3(h); provided, further, that any amendment or waiver of Section 2.3(h) shall require the written consent of Meritech Capital Partners IV L.P. (and its affiliated entities); provided,
further, that any amendment or waiver of Section 2.3 that limits or removes the rights of the Series F Holders shall require the written consent of the holders of at least sixty-six and two/thirds percent (66 2/3%) of the Registrable
Securities held by the Series F Holders; provided, further, that any amendment or waiver of Section 2.4 that limits or removes the rights of an Observer to the rights set forth herein shall require the written consent of the
affiliated Observer Rights Holder; provided, further, that any amendment or waiver of Sections 1.2(a)(ii), 1.2(c)(3), 1.4 (to the extent that such amendment or waiver would prohibit any TPG Stockholder from exercising the right to
request the Company file a Shelf Registration Statement thereunder), the last sentence of 1.14, 2.1 (to the extent such amendment or waiver would prohibit any TPG Stockholder that is a Series F Holder from exercising the rights of a Major Investor
hereunder), 2.3 (to the extent such amendment or waiver would amend, waive, or limit the rights of any TPG Stockholder with respect to an offering of Additional Shares of Common Stock), 2.4 (to the extent such amendment or waiver would amend, waive,
or limit the rights of any TPG Stockholder with respect to appoint an Observer), 2.6 (to the extent such amendment or waiver would amend, waive, or limit the rights of the member of the Board of Directors designated by TPG Bogota Holdings, L.P. or
the Series F Preferred to be a member of all committees of the Board of Directors or, if not a member, to attend all such committee meetings), 2.9(b)(1), 2.9(d) or this proviso of Section 3.7 shall require the written consent of the holders of
at least sixty-six and two/thirds percent (66-2/3%) of the Registrable Securities held by the TPG Stockholders; 

  
 27 

 
provided, further, that any amendment or waiver of Section 1.2(a)(i) or Section 2.3 shall require the prior written consent of the General Atlantic Stockholders
(provided, that, notwithstanding the foregoing or anything to the contrary, in this proviso applicable to the General Atlantic Stockholders, Holders of at least sixty-six and two/thirds percent (66-2/3%) of the Registrable Securities shall be
permitted to waive Section 2.3 for issuances of Additional Shares of Common Stock to operating companies or their related investment funds, provided that no venture capital fund, private equity fund or other fund or entity whose
principal purpose is investment related (other than investment funds of operating companies) participates in such issuance); provided, further, that any amendment or waiver of Section 2.9(c) shall require the prior written consent
of Intel Capital Corporation and Telstra; provided, further, that in the event that such amendment or waiver adversely affects the obligations or rights of the Founders or the Investors in a different manner than the other Holders,
such amendment or waiver shall also require the written consent of the holders of a majority in interest of the Founders or the Investors, as applicable. Notwithstanding the foregoing, this Agreement may not be amended or modified and the observance
of any term of this Agreement may not be waived with respect to any Investor without the written consent of such Investor unless such amendment, modification or waiver (x) applies to all Investors in the same fashion, (y) does not
explicitly adversely affect such Investor in a manner differently than other Investors and (z) does not impose any additional obligations or liabilities on, or increases any liabilities or obligations of, such Investor under Section 2.9.
Any amendment or waiver effected in accordance with this paragraph shall be binding upon each Holder of any Registrable Securities, each future Holder of any Registrable Securities and the Company. Notwithstanding the foregoing, the Company may
amend this Agreement solely to add a party who after the date of this Agreement acquires shares of the Company’s Series F Preferred pursuant to the terms of the Purchase Agreement. Any such additional party, by executing a counterpart
signature page to this Agreement, shall become an Investor for all purposes and shall be bound by all of the applicable provisions under this Agreement. Any amendment or waiver effected in accordance with this paragraph shall be binding upon each
Holder of any Registrable Securities, each future Holder of any Registrable Securities and the Company. The Company shall give prompt written notice of any amendment or termination hereof or waiver hereunder to any party hereto that did not consent
in writing to such amendment, termination or waiver. 
  

	 	3.8	Severability 

 If one or more provisions of this Agreement are held to be
unenforceable under applicable law, such provision shall be excluded from this Agreement and the balance of the Agreement shall be interpreted as if such provision were so excluded and shall be enforceable in accordance with its terms. 

 

	 	3.9	Aggregation of Stock 

 All shares of Registrable Securities held or acquired by
affiliated entities or persons shall be aggregated together for the purpose of determining the availability of any rights under this Agreement. 

  
 28 

	 	3.10	Expenses 

 If any action at law or in equity is necessary to enforce or interpret
the terms of this Agreement, the prevailing party shall be entitled to reasonable attorneys’ fees, costs and necessary disbursements in addition to any other relief to which such party may be entitled. 

 

	 	3.11	Further Assurances 

 Each party hereto agrees to execute and deliver, by the
proper exercise of its corporate, limited liability company, partnership or other powers, all such other and additional instruments and documents and do all such other acts and things as may be necessary to more fully effectuate this Agreement. 

 

	 	3.12	Arbitration 

 In the event of any dispute arising hereunder or related hereto, the
parties shall first attempt to resolve such dispute though informal negotiations. Any dispute not resolved through informal negotiations shall be resolved by binding arbitration before a single arbitrator sitting in Northern California, acting under
the expedited commercial rules of the American Arbitration Association. The cost of the arbitration shall initially be shared equally between the parties, provided that the arbitrator shall order such cost, along with any legal costs pursuant
to Section 3.10, borne by the non-prevailing party. Nothing herein shall preclude resorting to courts of competent jurisdiction for requests for preliminary injunctive relief or other such relief which cannot practicably be obtained through
such arbitration procedure. Each party hereby consents to the exclusive jurisdiction of, and venue in, the federal and state courts located in Northern California with subject matter jurisdiction over the matter in controversy, for any matter
appropriately brought before a court pursuant to this Section 3.12. 
 [SIGNATURE PAGES FOLLOW] 

  
 29 

 IN WITNESS WHEREOF, the parties have executed this Eighth Amended and Restated Investors’
Rights Agreement as of the date first above written. 
  

	
	COMPANY:
	
	BOX, INC.
	
	 /s/ Aaron Levie

	Aaron Levie
	Chief Executive Officer

  
 SIGNATURE PAGE TO

 EIGHT AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this Eighth Amended and Restated Investors’
Rights Agreement as of the date first above written. 
  

			
	FOUNDERS:
	
	 /s/ Aaron Levie

	Aaron Levie
	
	 /s/ Dylan Smith

	Dylan Smith
	
	DCS GRAT OF 2014
		
	By:	 	 /s/ Dylan Smith

		 	Dylan Smith, Trustee

  
 SIGNATURE PAGE TO

 EIGHT AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this Eighth Amended and Restated Investors’
Rights Agreement as of the date first above written. 
  

					
	INVESTORS:
	
	TPG BOGOTA HOLDINGS, L.P.
		
	By:	 	TPG Growth II Advisors, Inc., its General Partner
		
	By:	 	 /s/ Ronald Cami

		 	Name:	 	Ronald Cami
		 	Title:	 	Vice President

  
 SIGNATURE PAGE TO

 EIGHT AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this Eighth Amended and Restated Investors’
Rights Agreement as of the date first above written. 
  

					
	INVESTORS:
	
	 ANDREESSEN HOROWITZ FUND II, L.P.

as nominee for

	Andreessen Horowitz Fund II, L.P.
	Andreessen Horowitz Fund II-A, L.P. and
	Andreessen Horowitz Fund II-B, L.P.
		
	By:	 	 AH Equity Partners II, L.L.C.
 its
general partner

		
	By:	 	 /s/ Scott Kupor

		 	Name:	 	Scott Kupor
		 	Title:	 	COO
	
	AH ANNEX FUND, L.P.
		
	By:	 	 AH Equity Partners II, L.L.C.
 Its
general partner

		
	By:	 	 /s/ Scott Kupor

		 	Name:	 	Scott Kupor
		 	Title:	 	COO

  
 SIGNATURE PAGE TO

 EIGHT AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this Eighth Amended and Restated Investors’
Rights Agreement as of the date first above written. 
  

					
	INVESTORS:
	
	BESSEMER VENTURE PARTNERS VIII L.P.
	BESSEMER VENTURE PARTNERS VIII
	INSTITUTIONAL L.P.
		
	By:	 	Deer VIII & Co. L.P., their General Partner
	By:	 	Deer VIII & Co. Ltd., its General Partner
		
	By:	 	 /s/ J. Edmund Colloton

		 	Name:	 	J. Edmund Colloton
		 	Title:	 	Director

  
 SIGNATURE PAGE TO

 EIGHT AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 

 
			
	IN WITNESS WHEREOF, the parties have executed this Eighth Amended and Restated Investors’ Rights Agreement as of the date first above written.
	
	INVESTORS:
	
	COATUE MANAGEMENT, L.L.C.
	On behalf of Coatue Offshore Master Fund, Ltd.
		
	By:	 	 /s/ Colleen Lynch

	Name:	 	 Colleen Lynch

	Title:	 	 Authorized Signatory

	
	COATUE PRIVATE FUND I LP
	By:	 	Coatue Hybrid GP I LLC, its general partner
		
	By:	 	 /s/ Colleen Lynch

	Name:	 	 Colleen Lynch

	Title:	 	 Authorized Signatory

  
 SIGNATURE PAGE TO

 EIGHT AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this Eighth Amended and Restated Investors’
Rights Agreement as of the date first above written. 
  

					
	INVESTORS:
	
	DRAPER FISHER JURVETSON GROWTH FUND 2006, L.P.
		
	By:	 	 /s/ Mark W. Bailey

	Name:	 	 Mark W. Bailey

	Title:	 	 Director

	
	DRAPER FISHER JURVETSON PARTNERS GROWTH FUND 2006, LLC
		
	By:	 	 /s/ Mark W. Bailey

		 	Name:	 	Mark W. Bailey
		 	Title:	 	Authorized Member
	
	DRAPER FISHER JURVETSON FUND VIII, L.P.
		
	By:	 	 /s/ John Fisher

		 	Name:	 	John Fisher
		 	Title:	 	Managing Director
	
	DRAPER FISHER JURVETSON PARTNERS VIII, LLC
		
	By:	 	 /s/ John Fisher

		 	Name:	 	John Fisher
		 	Title:	 	Managing Member
	
	DRAPER ASSOCIATES, L.P.
		
	By:	 	 /s/ Timothy C. Draper

		 	Name:	 	Timothy C. Draper
		 	Title:	 	General Partner

  
 SIGNATURE PAGE TO

 EIGHT AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this Eighth Amended and Restated Investors’
Rights Agreement as of the date first above written. 
  

					
	INVESTORS:
	
	DRAPER FISHER JURVETSON FUND IX, L.P.
		
	By:	 	 /s/ John Fisher

		 	Name:	 	John Fisher
		 	Title:	 	Managing Director
	
	DRAPER FISHER JURVETSON PARTNERS IX, LLC
		
	By:	 	 /s/ John Fisher

		 	Name:	 	John Fisher
		 	Title:	 	Managing Member

  
 SIGNATURE PAGE TO

 EIGHT AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this Eighth Amended and Restated Investors’
Rights Agreement as of the date first above written. 
  

			
	INVESTORS:
	
	DST GLOBAL III, L.P.
	By:	 	DST Managers Limited, its General Partner
		
	By:	 	 /s/ Sara Hollinrake

	Name:	 	Sara Hollinrake
	Title:	 	Director
	
	DST GLOBAL III-B, L.P.
	By:	 	DST Managers Limited, its General Partner
		
	By:	 	 /s/ Sara Hollinrake

	Name:	 	Sara Hollinrake
	Title:	 	Director

  
 SIGNATURE PAGE TO

 EIGHT AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first above written.

  

					
	INVESTOR:
	
	GENERAL ATLANTIC PARTNERS 90, L.P.
	By: 	 	General Atlantic GenPar, L.P., its General Partner
	By:	 	General Atlantic LLC, its General Partner
		
	By:	 	 /s/ David Rosenstein

		 	Name:	 	David Rosenstein
		 	Title:	 	Managing Director
	
	GAP COINVESTMENTS III, LLC
	By:	 	General Atlantic LLC, its Managing Member
		
	By:	 	 /s/ David Rosenstein

		 	Name:	 	David Rosenstein
		 	Title:	 	Managing Director

  
 SIGNATURE PAGE TO

 EIGHT AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first above written.

  

					
	INVESTOR:
	
	GAP COINVESTMENTS IV, LLC
	By:	 	General Atlantic LLC, its Managing Member
		
	By:	 	 /s/ David Rosenstein

		 	Name:	 	David Rosenstein
		 	Title:	 	Managing Director
	
	GAP COINVESTMENTS CDA, L.P.
	By:	 	General Atlantic LLC, its General Partner
		
	By:	 	 /s/ David Rosenstein

		 	Name:	 	David Rosenstein
		 	Title:	 	Managing Director
	
	GAPCO GMBH & CO. KG
	By:	 	GAPCO Management GmbH, its General Partner
		
	By:	 	 /s/ David Rosenstein

		 	Name:	 	David Rosenstein
		 	Title:	 	Managing Director

  
 SIGNATURE PAGE TO

 EIGHT AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this Eighth Amended and Restated Investors’
Rights Agreement as of the date first above written. 
  

					
	INVESTORS:
	
	MERITECH CAPITAL PARTNERS IV L.P.
		
	By:	 	Meritech Capital Associates IV L.L.C.
		 	its General Partner
		
	By:	 	 /s/ George Bischof

		 	Name:	 	George Bischof
		 	Title:	 	Managing Director
	
	MERITECH CAPITAL AFFILIATES IV L.P.
		
	By:	 	Meritech Capital Associates IV L.L.C.
		 	its General Partner
		
	By:	 	 /s/ George Bischof

		 	Name:	 	George Bischof
		 	Title:	 	Managing Director

  
 SIGNATURE PAGE TO

 EIGHT AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this Eighth Amended and Restated Investors’
Rights Agreement as of the date first above written. 
  

			
	INVESTORS:
	
	NEW ENTERPRISE ASSOCIATES 13, L.P.
	By:	 	NEA Partners 13, L.P., its general partner
	By:	 	NEA 13 GP, LTD, its general partner
		
	By:	 	 /s/ Louis S. Citron

	Name:	 	Louis S. Citron
	Title:	 	Chief Legal Officer
	
	NEA VENTURES 2011, LIMITED PARTNERSHIP
		
	By:	 	 /s/ Louis S. Citron

	Name:	 	Louis S. Citron
	Title:	 	Vice President

  
 SIGNATURE PAGE TO

 EIGHT AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this Eighth Amended and Restated Investors’
Rights Agreement as of the date first above written. 
  

					
	INVESTORS:
	
	SCALE VENTURE PARTNERS III, L.P.
		
	By:	 	Scale Venture Management III, LLC
	Its:	 	General Partner
		
	By:	 	 /s/ Rory O’Driscoll

		 	Name:	 	Rory O’Driscoll
		 	Title:	 	Managing Director

  
 SIGNATURE PAGE TO

 EIGHT AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this Eighth Amended and Restated Investors’
Rights Agreement as of the date first above written. 
  

					
	INVESTORS:
	
	U.S. VENTURE PARTNERS IX, L.P.
		
	By:	 	Presidio Management Group IX, L.L.C.
	Its:	 	General Partner
		
	By:	 	 /s/ Steven Krausz

		 	Name:	 	Steven Krausz
		 	Title:	 	Managing Member

  
 SIGNATURE PAGE TO

 EIGHT AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this Eighth Amended and Restated Investors’
Rights Agreement as of the date first above written. 
  

			
	INVESTORS:
	
	SAP VENTURES FUND I, L.P.
		
	By:	 	SAP VENTURES (GPE) I, LLC
	Its:	 	General Partner
		
	By:	 	 /s/ Jai Das

	Name:	 	Jai Das
	Title:	 	Managing Member
		
	By:	 	SAP VENTURES (GPE) I, LLC
	Its:	 	General Partner
		
	By:	 	 /s/ Nino Marakovic

	Name:	 	Nino Marakovic
	Title:	 	CEO & Managing Member

  
 SIGNATURE PAGE TO

 EIGHT AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 

 SCHEDULE A 

SCHEDULE OF EXISTING INVESTORS 

Scale Venture Partners III, L.P. 

Draper Fisher Jurvetson Fund VIII, L.P. 

Draper Fisher Jurvetson Partners VIII, LLC 

Draper Fisher Jurvetson Fund IX, L.P. 

Draper Fisher Jurvetson Partners IX, LLC 

Draper Associates, L.P. 
 U.S.
Venture Partners IX, L.P. 
 TWB Investment Partnership II, L.P. 

Hercules Technology II, L.P. 

Meritech Capital Affiliates IV L.P. 

Meritech Capital Partners IV L.P. 

Emergence Capital Partners II, L.P. 

Andreessen Horowitz Fund II, L.P. as nominee for 

Andreessen Horowitz Fund II, L.P. Andreessen Horowitz 

Fund II-A, L.P. and Andreessen Horowitz Fund II-B, L.P. 

Red Brick Investment Company, LLC 

Hercules Technology Growth Capital, Inc. 

The Board of Trustees of the 

Leland Stanford Junior University (SBST)

Direct Investments 
 Stanford
Management Company 
 Draper Fisher Jurvetson Growth Fund 2006, L.P. 

Draper Fisher Jurvetson Partners Growth Fund 2006, LLC 

AH Annex Fund, L.P. 
 SAP Ventures
Fund I, L.P. 

 salesforce.com, Inc. 

Bessemer Venture Partners VIII L.P. 

Bessemer Venture Partners VIII Institutional L.P. 

New Enterprise Associates 13, L.P. 

NEA Ventures 2011, Limited Partnership 

General Atlantic Partners 90, L.P. 

GAP Coinvestments III, LLC 
 GAP
Coinvestments IV, LLC 
 GAP Coinvestments CDA, L.P. 

GAPCO GMBH & CO. KG 
 The
Social+Capital Partnership, L.P. 
 The Social+Capital Partnership Principals Fund, L.P. 

Intel Capital Corporation 
 Coatue
Hybrid GP I LLC 

 SCHEDULE B 

SCHEDULE OF SERIES E-1 HOLDERS 

MITSUI & CO. (U.S.A.), INC. 

MITSUI KNOWLEDGE INDUSTRY CO., LTD. 

DST GLOBAL III, L.P. 
 DST GLOBAL
III-B, L.P. 
 COATUE PRIVATE FUND I LP 

MACNICA INVESTMENT PARTNERS 

DRAPER FISHER JURVESTSON GROWTH FUND 2006, L.P. 

DRAPER FISHER JURVESTSON PARTNERS GROWTH FUND 2006, LLC 

Technology Ventures III Venture Capital Investment Limited Partnership 

THE SOCIAL+CAPITAL PARTNERSHIP II, L.P., FOR ITSELF AND AS NOMINEE FOR CERTAIN OTHER INDIVIDUALS AND ENTITIES 

BESSEMER VENTURE PARTNERS VIII L.P. 

BESSEMER VENTURE PARTNERS VIII INSTITUTIONAL L.P. 

TELEFONICA DIGITAL VENTURE CAPITAL, S.L. 

TELSTRA VENTURES PTY LTD 
 JEREMY
STOPPELMAN TTEE UTD 3/16/10 
 ENRIQUE SALEM 

A-GRADE HOLDINGS, LLC 

 SCHEDULE C 

SCHEDULE OF SERIES F HOLDERS 

COATUE OFFSHORE MASTER FUND, LTD. 

COATUE PRIVATE FUND I LP 
 TPG
BOGOTA HOLDINGS, L.P. 

 SCHEDULE D 

SCHEDULE OF FOUNDERS 

Aaron Levie 
 Dylan Smith 

DCS GRAT OF 2014EX-10.1

 Exhibit 10.1 

BOX, INC. 

INDEMNIFICATION AGREEMENT 

This Indemnification Agreement (this “Agreement”) is dated as of
                 , 20     and is between Box, Inc., a Delaware corporation (the “Company”), and
                     (“Indemnitee”). 

RECITALS 
 A.
Indemnitee’s service to the Company substantially benefits the Company. 
 B. Individuals are reluctant to serve as directors or
officers of corporations or in certain other capacities unless they are provided with adequate protection through insurance or indemnification against the risks of claims and actions against them arising out of such service. 

C. Indemnitee does not regard the protection currently provided by applicable law, the Company’s governing documents and any insurance as
adequate under the present circumstances, and Indemnitee may not be willing to serve as a director or officer without additional protection. 

D. In order to induce Indemnitee to continue to provide services to the Company, it is reasonable, prudent and necessary for the Company to
contractually obligate itself to indemnify, and to advance expenses on behalf of, Indemnitee as permitted by applicable law. 
 E. This
Agreement is a supplement to and in furtherance of the indemnification provided in the Company’s certificate of incorporation and bylaws, and any resolutions adopted pursuant thereto, and this Agreement shall not be deemed a substitute
therefor, nor shall this Agreement be deemed to limit, diminish or abrogate any rights of Indemnitee thereunder. 
 The parties therefore
agree as follows: 
 1. Definitions. 

(a) A “Change in Control” shall be deemed to occur upon the earliest to occur after the date of this Agreement of any
of the following events: 
 (i) Acquisition of Stock by Third Party. Any Person (as defined below) is or becomes the Beneficial
Owner (as defined below), directly or indirectly, of securities of the Company representing fifteen percent (15%) or more of the combined voting power of the Company’s then outstanding securities; 

(ii) Change in Board Composition. During any period of two consecutive years (not including any period prior to the execution of this
Agreement), individuals who at the beginning of such period constitute the Company’s board of directors, and any new directors (other than a director designated by a person who has entered into an agreement with the Company to effect a
transaction described in Sections 1(a)(i), 1(a)(iii) or 1(a)(iv)) whose election by the board of directors or nomination for election by the Company’s stockholders was approved by a vote of at least
two-thirds of the directors then still in office who either were directors at the beginning of the period or whose election or nomination for election was previously so approved, cease for any reason to
constitute at least a majority of the members of the Company’s board of directors; 

 (iii) Corporate Transactions. The effective date of a merger or consolidation of the
Company with any other entity, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior to such merger or consolidation continuing to represent (either by remaining outstanding or
by being converted into voting securities of the surviving entity) more than 50% of the combined voting power of the voting securities of the surviving entity outstanding immediately after such merger or consolidation and with the power to elect at
least a majority of the board of directors or other governing body of such surviving entity; 
 (iv) Liquidation. The approval by
the stockholders of the Company of a complete liquidation of the Company or an agreement for the sale or disposition by the Company of all or substantially all of the Company’s assets; and 

(v) Other Events. Any other event of a nature that would be required to be reported in response to Item 6(e) of Schedule 14A
of Regulation 14A (or in response to any similar item on any similar schedule or form) promulgated under the Securities Exchange Act of 1934, as amended, whether or not the Company is then subject to such reporting requirement. 

For purposes of this Section 1(a), the following terms shall have the following meanings: 

(1) “Person” shall have the meaning as set forth in Sections 13(d) and 14(d) of the Securities Exchange Act of
1934, as amended; provided, however, that “Person” shall exclude (i) the Company, (ii) any trustee or other fiduciary holding securities under an employee benefit plan of the Company, and
(iii) any corporation owned, directly or indirectly, by the stockholders of the Company in substantially the same proportions as their ownership of stock of the Company. 

(2) “Beneficial Owner” shall have the meaning given to such term in
Rule 13d-3 under the Securities Exchange Act of 1934, as amended; provided, however, that “Beneficial Owner” shall exclude any Person otherwise becoming a Beneficial
Owner by reason of (i) the stockholders of the Company approving a merger of the Company with another entity or (ii) the Company’s board of directors approving a sale of securities by the Company to such Person. 

(b) “Corporate Status” describes the status of a person who is or was a director, trustee, general partner, managing
member, officer, employee, agent or fiduciary of the Company or any other Enterprise. 
 (c) “DGCL” means the
General Corporation Law of the State of Delaware. 
 (d) “Disinterested Director” means a director of the Company
who is not and was not a party to the Proceeding in respect of which indemnification is sought by Indemnitee. 
 (e)
“Enterprise” means the Company and any other corporation, partnership, limited liability company, joint venture, trust, employee benefit plan or other enterprise of which Indemnitee is or was serving at the request of the
Company as a director, trustee, general partner, managing member, officer, employee, agent or fiduciary. 

  
 -2- 

 (f) “Expenses” include all reasonable attorneys’ fees,
retainers, court costs, transcript costs, fees and costs of experts, witness fees, travel expenses, duplicating costs, printing and binding costs, telephone charges, postage, delivery service fees, and all other disbursements or expenses of the
types customarily incurred in connection with prosecuting, defending, preparing to prosecute or defend, investigating, being or preparing to be a witness in, or otherwise participating in, a Proceeding. Expenses also include (i) Expenses
incurred in connection with any appeal resulting from any Proceeding, including without limitation the premium, security for, and other costs relating to any cost bond, supersedeas bond or other appeal bond or their equivalent, and (ii) for
purposes of Section 12(d), Expenses incurred by Indemnitee in connection with the interpretation, enforcement or defense of Indemnitee’s rights under this Agreement or under any directors’ and officers’ liability insurance
policies maintained by the Company. Expenses, however, shall not include amounts paid in settlement by Indemnitee or the amount of judgments or fines against Indemnitee. 

(g) “Independent Counsel” means a law firm, or a partner or member of a law firm, that is experienced in
matters of corporation law and neither presently is, nor in the past five years has been, retained to represent (i) the Company or Indemnitee in any matter material to either such party (other than as Independent Counsel with respect to matters
concerning Indemnitee under this Agreement, or other indemnitees under similar indemnification agreements), or (ii) any other party to the Proceeding giving rise to a claim for indemnification hereunder. Notwithstanding the foregoing, the term
“Independent Counsel” shall not include any person who, under the applicable standards of professional conduct then prevailing, would have a conflict of interest in representing either the Company or Indemnitee in an action
to determine Indemnitee’s rights under this Agreement. 
 (h) “Proceeding” means
any threatened, pending or completed action, suit, arbitration, mediation, alternate dispute resolution mechanism, investigation, inquiry, administrative hearing or proceeding, whether brought in the right of the Company or otherwise and whether of
a civil, criminal, administrative or investigative nature, including any appeal therefrom and including without limitation any such Proceeding pending as of the date of this Agreement, in which Indemnitee was, is or will be involved as a party, a
potential party, a non-party witness or otherwise by reason of (i) the fact that Indemnitee is or was a director or officer of the Company, (ii) any action taken by Indemnitee or any action or
inaction on Indemnitee’s part while acting as a director or officer of the Company, or (iii) the fact that he or she is or was serving at the request of the Company as a director, trustee, general partner, managing member, officer,
employee, agent or fiduciary of the Company or any other Enterprise, in each case whether or not serving in such capacity at the time any liability or Expense is incurred for which indemnification or advancement of expenses can be provided under
this Agreement. 
 (i) Reference to “other enterprises” shall include employee benefit
plans; references to “fines” shall include any excise taxes assessed on a person with respect to any employee benefit plan; references to “serving at the request of the Company” shall include any
service as a director, officer, employee or agent of the Company which imposes duties on, or 

  
 -3- 

 
involves services by, such director, officer, employee or agent with respect to an employee benefit plan, its participants or beneficiaries; and a person who acted in good
faith and in a manner he or she reasonably believed to be in the best interests of the participants and beneficiaries of an employee benefit plan shall be deemed to have acted in a manner “not opposed to the best interests of the
Company” as referred to in this Agreement. 
 2. Indemnity in
Third-Party Proceedings. The Company shall indemnify Indemnitee in accordance with the provisions of this Section 2 if Indemnitee is, or is threatened to be made, a party to or a participant in
any Proceeding, other than a Proceeding by or in the right of the Company to procure a judgment in its favor. Pursuant to this Section 2, Indemnitee shall be indemnified to the fullest extent permitted by applicable law against all Expenses,
judgments, fines and amounts paid in settlement actually and reasonably incurred by Indemnitee or on his or her behalf in connection with such Proceeding or any claim, issue or matter therein, if Indemnitee acted in good faith and in a manner he or
she reasonably believed to be in or not opposed to the best interests of the Company and, with respect to any criminal action or proceeding, had no reasonable cause to believe that his or her conduct was unlawful. 

3. Indemnity in Proceedings by or in the Right of the Company. The Company shall indemnify Indemnitee in accordance with the
provisions of this Section 3 if Indemnitee is, or is threatened to be made, a party to or a participant in any Proceeding by or in the right of the Company to procure a judgment in its favor. Pursuant to this Section 3, Indemnitee shall be
indemnified to the fullest extent permitted by applicable law against all Expenses actually and reasonably incurred by Indemnitee or on Indemnitee’s behalf in connection with such Proceeding or any claim, issue or matter therein, if Indemnitee
acted in good faith and in a manner he or she reasonably believed to be in or not opposed to the best interests of the Company. No indemnification for Expenses shall be made under this Section 3 in respect of any claim, issue or matter as to
which Indemnitee shall have been adjudged by a court of competent jurisdiction to be liable to the Company, unless and only to the extent that the Delaware Court of Chancery or any court in which the Proceeding was brought shall determine upon
application that, despite the adjudication of liability but in view of all the circumstances of the case, Indemnitee is fairly and reasonably entitled to indemnification for such expenses as the Delaware Court of Chancery or such other court shall
deem proper. 
 4. Indemnification for Expenses of a Party Who is Wholly or Partly Successful. To the extent that
Indemnitee is a party to or a participant in and is successful (on the merits or otherwise) in defense of any Proceeding or any claim, issue or matter therein, the Company shall indemnify Indemnitee against all Expenses actually and reasonably
incurred by Indemnitee or on Indemnitee’s behalf in connection therewith. To the extent permitted by applicable law, if Indemnitee is not wholly successful in such Proceeding but is successful, on the merits or otherwise, in defense of one or
more but less than all claims, issues or matters in such Proceeding, the Company shall indemnify Indemnitee against all Expenses actually and reasonably incurred by Indemnitee or on Indemnitee’s behalf in connection with (a) each
successfully resolved claim, issue or matter, and (b) any claim, issue or matter related to any such successfully resolved claim, issue or matter. For purposes of this section, the termination of any claim, issue or matter in such a Proceeding
by dismissal, with or without prejudice, shall be deemed to be a successful result as to such claim, issue or matter. 

  
 -4- 

 5. Indemnification for Expenses of a Witness. To the extent that Indemnitee is, by
reason of his or her Corporate Status, a witness in any Proceeding to which Indemnitee is not a party, Indemnitee shall be indemnified to the extent permitted by applicable law against all Expenses actually and reasonably incurred by Indemnitee or
on Indemnitee’s behalf in connection therewith. 
 6. Additional Indemnification. 

(a) Notwithstanding any limitation in Sections 2, 3 or 4, the Company shall indemnify Indemnitee to the fullest extent permitted by
applicable law if Indemnitee is, or is threatened to be made, a party to or a participant in any Proceeding (including a Proceeding by or in the right of the Company to procure a judgment in its favor) against all Expenses, judgments, fines and
amounts paid in settlement actually and reasonably incurred by Indemnitee or on his or her behalf in connection with the Proceeding or any claim, issue or matter therein. 

(b) For purposes of Section 6(a), the meaning of the phrase “to the fullest extent permitted by applicable law”
shall include, but not be limited to: 
 (i) the fullest extent permitted by the provision of the DGCL that authorizes or contemplates
additional indemnification by agreement, or the corresponding provision of any amendment to or replacement of the DGCL; and 
 (ii) the
fullest extent authorized or permitted by any amendments to or replacements of the DGCL adopted after the date of this Agreement that increase the extent to which a corporation may indemnify its officers and directors. 

7. Exclusions. Notwithstanding any provision in this Agreement, the Company shall not be obligated under this Agreement to make
any indemnity in connection with any Proceeding (or any part of any Proceeding): 
 (a) for which payment has actually been made to
or on behalf of Indemnitee under any statute, insurance policy, indemnity provision, vote or otherwise, except with respect to any excess beyond the amount paid; 

(b) for an accounting or disgorgement of profits pursuant to Section 16(b) of the Securities Exchange Act of 1934, as amended, or similar
provisions of federal, state or local statutory law or common law, if Indemnitee is held liable therefor; 
 (c) for any reimbursement of
the Company by Indemnitee of any bonus or other incentive-based or equity-based compensation or of any profits realized by Indemnitee from the sale of securities of the Company, as required in each case under the Securities Exchange Act of 1934, as
amended (including any such reimbursements that arise from an accounting restatement of the Company pursuant to Section 304 of the Sarbanes-Oxley Act of 2002 (the “Sarbanes-Oxley Act”), or the payment to the Company of profits arising from the purchase and sale by Indemnitee of securities in violation of Section 306 of the
Sarbanes-Oxley Act), if Indemnitee is held liable therefor; 

  
 -5- 

 (d) initiated by Indemnitee and not by way of defense, including any Proceeding (or any part of
any Proceeding) initiated by Indemnitee against the Company or its directors, officers, employees, agents or other indemnitees, unless (i) the Company’s board of directors authorized the Proceeding (or the relevant part of the Proceeding)
prior to its initiation, (ii) the Company provides the indemnification, in its sole discretion, pursuant to the powers vested in the Company under applicable law, (iii) otherwise authorized in Section 12(d) or (iv) otherwise
required by applicable law; or 
 (e) if prohibited by applicable law. 

8. Advances of Expenses. 

(a) The Company shall advance the Expenses incurred by Indemnitee in connection with any Proceeding prior to its final resolution, and such
advancement shall be made as soon as reasonably practicable, but in any event no later than 60 days, after the receipt by the Company of a written statement or statements requesting such advances from time to time (which shall include invoices
received by Indemnitee in connection with such Expenses but, in the case of invoices in connection with legal services, any references to legal work performed or to expenditure made that would cause Indemnitee to waive any privilege accorded by
applicable law shall not be included with the invoice). Advances shall be unsecured and interest free and made without regard to Indemnitee’s ability to repay such advances. Indemnitee hereby undertakes to repay any advance to the extent that
it is ultimately determined that Indemnitee is not entitled to be indemnified by the Company. This Section 8 shall not apply to the extent advancement is prohibited by law and shall not apply to any Proceeding for which indemnity is not
permitted under this Agreement, but shall apply to any Proceeding referenced in Section 7(b) or 7(c) prior to a determination that Indemnitee is not entitled to be indemnified by the Company. 

9. Procedures for Notification and Defense of Claim. 

(a) Indemnitee shall notify the Company in writing of any matter with respect to which Indemnitee intends to seek indemnification or
advancement of Expenses as soon as reasonably practicable following the receipt by Indemnitee of notice thereof. The written notification to the Company shall include, in reasonable detail, a description of the nature of the Proceeding and the facts
underlying the Proceeding. The failure by Indemnitee to notify the Company will not relieve the Company from any liability which it may have to Indemnitee hereunder or otherwise than under this Agreement, except to the extent that such failure or
delay materially prejudices the Company. 
 (b) If, at the time of the receipt of a notice of a Proceeding pursuant to the terms hereof, the
Company has directors’ and officers’ liability insurance in effect, the Company shall give prompt notice of the commencement of the Proceeding to the insurers in accordance with the procedures set forth in the applicable policies. The
Company shall thereafter take all commercially-reasonable action to cause such insurers to pay, on behalf of Indemnitee, all amounts payable as a result of such Proceeding in accordance with the terms of such policies. 

  
 -6- 

 (c) In the event the Company may be obligated to make any indemnity in connection with a
Proceeding, the Company shall be entitled to assume the defense of such Proceeding with counsel approved by Indemnitee, which approval shall not be unreasonably withheld. After the retention of such counsel by the Company, the Company will not be
liable to Indemnitee for any fees or expenses of counsel subsequently incurred by Indemnitee with respect to the same Proceeding. Notwithstanding the Company’s assumption of the defense of any such Proceeding, the Company shall be obligated to
pay the fees and expenses of Indemnitee’s separate counsel to the extent (i) the employment of separate counsel by Indemnitee is authorized by the Company, (ii) counsel for the Company or Indemnitee shall have reasonably concluded
that there is a conflict of interest between the Company and Indemnitee in the conduct of any such defense such that Indemnitee needs to be separately represented, (iii) the fees and expenses are
non-duplicative and reasonably incurred in connection with Indemnitee’s role in the Proceeding despite the Company’s assumption of the defense; (iv) the Company is not financially or legally
able to perform its indemnification obligations, or (v) the Company shall not have retained, or shall not continue to retain, such counsel to defend such Proceeding. The Company shall have the right to conduct such defense as it sees fit in its
sole discretion. Regardless of any provision in this Agreement, Indemnitee shall have the right to employ counsel in any Proceeding at Indemnitee’s personal expense. The Company shall not be entitled, without the consent of Indemnitee, to
assume the defense of any claim brought by or in the right of the Company. 
 (d) Indemnitee shall give the Company such information and
cooperation in connection with the Proceeding as may be reasonably appropriate. 
 (e) The Company shall not be liable to indemnify
Indemnitee for any settlement of any Proceeding (or any part thereof) without the Company’s prior written consent, which shall not be unreasonably withheld. 

(f) The Company shall not settle any Proceeding (or any part thereof) in a manner that imposes any penalty or liability on Indemnitee without
Indemnitee’s prior written consent, which may be withheld by Indemnitee in Indemnitee’s sole discretion. 
 10. Procedures upon
Application for Indemnification. 
 (a) To obtain indemnification, Indemnitee shall submit to the Company a written request, including
therein or therewith such documentation and information as is reasonably available to Indemnitee and as is reasonably necessary to determine whether and to what extent Indemnitee is entitled to indemnification following the final disposition
of the Proceeding. Any delay in providing the request will not relieve the Company from its obligations under this Agreement, except to the extent such failure is prejudicial. 

(b) Upon written request by Indemnitee for indemnification pursuant to Section 10(a), a determination with respect to Indemnitee’s
entitlement thereto shall be made in the specific case (i) if a Change in Control shall have occurred, by Independent Counsel in a written opinion to the Company’s board of directors, a copy of which shall be delivered to Indemnitee or
(ii) if a Change in Control shall not have occurred, if required by applicable law (A) by a majority vote of the Disinterested Directors, even though less than a quorum of the Company’s board of

  
 -7- 

 
directors, (B) by a committee of Disinterested Directors designated by a majority vote of the Disinterested Directors, even though less than a quorum of the Company’s board of
directors, (C) if there are no such Disinterested Directors or, if such Disinterested Directors so direct, by Independent Counsel in a written opinion to the Company’s board of directors, a copy of which shall be delivered to Indemnitee or
(D) if so directed by the Company’s board of directors, by the stockholders of the Company. If it is determined that Indemnitee is entitled to indemnification, payment to Indemnitee shall be made within ten days after such determination.
Indemnitee shall cooperate with the person, persons or entity making the determination with respect to Indemnitee’s entitlement to indemnification, including providing to such person, persons or entity upon reasonable advance request any
documentation or information that is not privileged or otherwise protected from disclosure and that is reasonably available to Indemnitee and reasonably necessary to such determination. Any costs or expenses (including attorneys’ fees and
disbursements) reasonably incurred by Indemnitee in so cooperating with the person, persons or entity making such determination shall be borne by the Company, to the extent permitted by applicable law. 

(c) In the event the determination of entitlement to indemnification is to be made by Independent Counsel pursuant to Section 10(b), the
Independent Counsel shall be selected as provided in this Section 10(c). If a Change in Control shall not have occurred, the Independent Counsel shall be selected by the Company’s board of directors, and the Company shall give written
notice to Indemnitee advising him or her of the identity of the Independent Counsel so selected. If a Change in Control shall have occurred, the Independent Counsel shall be selected by Indemnitee (unless Indemnitee shall request that such selection
be made by the Company’s board of directors, in which event the preceding sentence shall apply), and Indemnitee shall give written notice to the Company advising it of the identity of the Independent Counsel so selected. In either event,
Indemnitee or the Company, as the case may be, may, within ten days after such written notice of selection shall have been given, deliver to the Company or to Indemnitee, as the case may be, a written objection to such selection; provided,
however, that such objection may be asserted only on the ground that the Independent Counsel so selected does not meet the requirements of “Independent Counsel” as defined in Section 1 of this Agreement, and the objection shall
set forth with particularity the factual basis of such assertion. Absent a proper and timely objection, the person so selected shall act as Independent Counsel. If such written objection is so made and substantiated, the Independent Counsel so
selected may not serve as Independent Counsel unless and until such objection is withdrawn or a court has determined that such objection is without merit. If, within 20 days after the later of (i) submission by Indemnitee of a written request
for indemnification pursuant to Section 10(a) hereof and (ii) the final disposition of the Proceeding, the parties have not agreed upon an Independent Counsel, either the Company or Indemnitee may petition a court of competent jurisdiction
for resolution of any objection which shall have been made by the Company or Indemnitee to the other’s selection of Independent Counsel and for the appointment as Independent Counsel of a person selected by the court or by such other person as
the court shall designate, and the person with respect to whom all objections are so resolved or the person so appointed shall act as Independent Counsel under Section 10(b) hereof. Upon the due commencement of any judicial proceeding or
arbitration pursuant to Section 12(a) of this Agreement, the Independent Counsel shall be discharged and relieved of any further responsibility in such capacity (subject to the applicable standards of professional conduct then prevailing). The
Company shall pay the reasonable fees and expenses of any Independent Counsel. 

  
 -8- 

 11. Presumptions and Effect of Certain Proceedings. 

(a) In making a determination with respect to entitlement to indemnification hereunder, the person, persons or entity making such
determination shall, to the fullest extent not prohibited by law, presume that Indemnitee is entitled to indemnification under this Agreement, and the Company shall, to the fullest extent not prohibited by law, have the burden of proof to overcome
that presumption. 
 (b) The termination of any Proceeding or of any claim, issue or matter therein, by judgment, order, settlement or
conviction, or upon a plea of nolo contendere or its equivalent, shall not (except as otherwise expressly provided in this Agreement) of itself create a presumption that Indemnitee did not act in good faith and in a manner which he or she
reasonably believed to be in or not opposed to the best interests of the Company or, with respect to any criminal Proceeding, that Indemnitee had reasonable cause to believe that his or her conduct was unlawful. 

(c) Neither the knowledge, actions nor failure to act of any other director, officer, agent or employee of the Enterprise shall be imputed to
Indemnitee for purposes of determining the right to indemnification under this Agreement. 
 12. Remedies of Indemnitee. 

(a) Subject to Section 12(e), in the event that (i) a determination is made pursuant to Section 10 of this Agreement that
Indemnitee is not entitled to indemnification under this Agreement, (ii) advancement of Expenses is not timely made pursuant to Section 8 or 12(d) of this Agreement, (iii) no determination of entitlement to indemnification shall have
been made pursuant to Section 10 of this Agreement within 90 days after the later of the receipt by the Company of the request for indemnification or the final disposition of the Proceeding, (iv) payment of indemnification pursuant to this
Agreement is not made (A) within ten days after a determination has been made that Indemnitee is entitled to indemnification or (B) with respect to indemnification pursuant to Sections 4, 5 and 12(d) of this Agreement, within 30 days
after receipt by the Company of a written request therefor, or (v) the Company or any other person or entity takes or threatens to take any action to declare this Agreement void or unenforceable, or institutes any litigation or other action or
proceeding designed to deny, or to recover from, Indemnitee the benefits provided or intended to be provided to Indemnitee hereunder, Indemnitee shall be entitled to an adjudication by a court of competent jurisdiction of his or her entitlement to
such indemnification or advancement of Expenses. Alternatively, Indemnitee, at his or her option, may seek an award in arbitration with respect to his or her entitlement to such indemnification or advancement of Expenses, to be conducted by a single
arbitrator pursuant to the Commercial Arbitration Rules of the American Arbitration Association. Indemnitee shall commence such proceeding seeking an adjudication or an award in arbitration within 180 days following the date on which Indemnitee
first has the right to commence such proceeding pursuant to this Section 12(a); provided, however, that the foregoing clause shall not apply in respect of a proceeding brought by Indemnitee to enforce his or her rights under
Section 4 of this Agreement. The Company shall not oppose Indemnitee’s right to seek any such adjudication or award in arbitration in accordance with this Agreement. 

  
 -9- 

 (b) Neither (i) the failure of the Company, its board of directors, any committee or
subgroup of the board of directors, Independent Counsel or stockholders to have made a determination that indemnification of Indemnitee is proper in the circumstances because Indemnitee has met the applicable standard of conduct, nor (ii) an
actual determination by the Company, its board of directors, any committee or subgroup of the board of directors, Independent Counsel or stockholders that Indemnitee has not met the applicable standard of conduct, shall create a presumption that
Indemnitee has or has not met the applicable standard of conduct. In the event that a determination shall have been made pursuant to Section 10 of this Agreement that Indemnitee is not entitled to indemnification, any judicial proceeding or
arbitration commenced pursuant to this Section 12 shall be conducted in all respects as a de novo trial, or arbitration, on the merits, and Indemnitee shall not be prejudiced by reason of that adverse determination. In any
judicial proceeding or arbitration commenced pursuant to this Section 12, the Company shall, to the fullest extent not prohibited by law, have the burden of proving Indemnitee is not entitled to indemnification or advancement of Expenses, as
the case may be. 
 (c) To the fullest extent not prohibited by law, the Company shall be precluded from asserting in any judicial
proceeding or arbitration commenced pursuant to this Section 12 that the procedures and presumptions of this Agreement are not valid, binding and enforceable and shall stipulate in any such court or before any such arbitrator that the Company
is bound by all the provisions of this Agreement. If a determination shall have been made pursuant to Section 10 of this Agreement that Indemnitee is entitled to indemnification, the Company shall be bound by such determination in any judicial
proceeding or arbitration commenced pursuant to this Section 12, absent (i) a misstatement by Indemnitee of a material fact, or an omission of a material fact necessary to make Indemnitee’s statements not materially misleading, in
connection with the request for indemnification, or (ii) a prohibition of such indemnification under applicable law. 
 (d) To the
extent not prohibited by law, the Company shall indemnify Indemnitee against all Expenses that are incurred by Indemnitee in connection with any action for indemnification or advancement of Expenses from the Company under this Agreement or under any
directors’ and officers’ liability insurance policies maintained by the Company, unless the court (or arbitrator) finds that each material argument or defense advanced by Indemnitee in such action or arbitration was either frivolous or not
made in good faith. Further, if requested by Indemnitee, the Company shall (as soon as reasonably practicable, but in any event no later than 60 days, after receipt by the Company of a written request therefor) advance such Expenses to Indemnitee,
subject to the provisions of Section 8, subject to Indemnitee’s agreement to repay the sums advanced if the court (or arbitrator) finds that each material argument or defense advanced by Indemnitee in such action or arbitration was either
frivolous or not made in good faith. 
 (e) Notwithstanding anything in this Agreement to the contrary, no determination as to entitlement
to indemnification shall be required to be made prior to the final disposition of the Proceeding. 
 13. Contribution. To the fullest
extent permissible under applicable law, if the indemnification provided for in this Agreement is unavailable to Indemnitee, the Company, in lieu of indemnifying Indemnitee, shall contribute to the amounts incurred by Indemnitee, whether for
Expenses, judgments, fines or amounts paid or to be paid in settlement, in connection with any claim 

  
 -10- 

 
relating to an indemnifiable event under this Agreement, in such proportion as is deemed fair and reasonable in light of all of the circumstances of such Proceeding in order to reflect
(i) the relative benefits received by the Company and Indemnitee as a result of the events and transactions giving rise to such Proceeding; and (ii) the relative fault of Indemnitee and the Company (and its other directors, officers,
employees and agents) in connection with such events and transactions. 
 14.
Non-exclusivity. The rights of indemnification and to receive advancement of Expenses as provided by this Agreement shall not be deemed exclusive of any other rights to which Indemnitee may at any time
be entitled under applicable law, the Company’s certificate of incorporation or bylaws, any agreement, a vote of stockholders or a resolution of directors, or otherwise. To the extent that a change in Delaware law, whether by statute or
judicial decision, permits greater indemnification or advancement of Expenses than would be afforded currently under the Company’s certificate of incorporation and bylaws and this Agreement, it is the intent of the parties hereto that
Indemnitee shall enjoy by this Agreement the greater benefits so afforded by such change, subject to the restrictions expressly set forth herein or therein. Except as expressly set forth herein, no right or remedy herein conferred is intended to be
exclusive of any other right or remedy, and every other right and remedy shall be cumulative and in addition to every other right and remedy given hereunder or now or hereafter existing at law or in equity or otherwise. Except as expressly set forth
herein, the assertion or employment of any right or remedy hereunder, or otherwise, shall not prevent the concurrent assertion or employment of any other right or remedy. 

15. Primary Responsibility. The Company acknowledges that to the extent Indemnitee is serving as a director on the
Company’s board of directors at the request or direction of a venture capital fund or other entity and/or certain of its affiliates (collectively, the “Secondary Indemnitors”), Indemnitee may have certain
rights to indemnification and advancement of expenses provided by such Secondary Indemnitors. The Company agrees that, as between the Company and the Secondary Indemnitors, the Company is primarily responsible for amounts required to be indemnified
or advanced under the Company’s certificate of incorporation or bylaws or this Agreement and any obligation of the Secondary Indemnitors to provide indemnification or advancement for the same amounts is secondary to those Company obligations.
To the extent not in contravention of any insurance policy or policies providing liability or other insurance for the Company or any director, trustee, general partner, managing member, officer, employee, agent or fiduciary of the Company or any
other Enterprise, the Company waives any right of contribution or subrogation against the Secondary Indemnitors with respect to the liabilities for which the Company is primarily responsible under this Section 15. In the event of any payment by
the Secondary Indemnitors of amounts otherwise required to be indemnified or advanced by the Company under the Company’s certificate of incorporation or bylaws or this Agreement, the Secondary Indemnitors shall be subrogated to the extent of
such payment to all of the rights of recovery of Indemnitee for indemnification or advancement of expenses under the Company’s certificate of incorporation or bylaws or this Agreement or, to the extent such subrogation is unavailable and
contribution is found to be the applicable remedy, shall have a right of contribution with respect to the amounts paid. The Secondary Indemnitors are express third-party beneficiaries of the terms of this
Section 15. 
 16. No Duplication of Payments. The Company shall not be liable under this Agreement to make any
payment of amounts otherwise indemnifiable hereunder (or for which advancement is provided hereunder) if and to the extent that Indemnitee has otherwise actually received payment for such amounts under any insurance policy, contract, agreement or
otherwise. 

  
 -11- 

 17. Insurance. To the extent that the Company maintains an insurance policy or
policies providing liability insurance for directors, trustees, general partners, managing members, officers, employees, agents or fiduciaries of the Company or any other Enterprise, Indemnitee shall be covered by such policy or policies to the same
extent as the most favorably-insured persons under such policy or policies in a comparable position. 
 18.
Subrogation. In the event of any payment under this Agreement, the Company shall be subrogated to the extent of such payment to all of the rights of recovery of Indemnitee, who shall execute all papers required and take all action necessary
to secure such rights, including execution of such documents as are necessary to enable the Company to bring suit to enforce such rights. 

19. Services to the Company. Indemnitee agrees to serve as a director or officer of the Company or, at the request of the
Company, as a director, trustee, general partner, managing member, officer, employee, agent or fiduciary of another Enterprise, for so long as Indemnitee is duly elected or appointed or until Indemnitee tenders his or her resignation or is removed
from such position. Indemnitee may at any time and for any reason resign from such position (subject to any other contractual obligation or any obligation imposed by operation of law), in which event the Company shall have no obligation under this
Agreement to continue Indemnitee in such position. This Agreement shall not be deemed an employment contract between the Company (or any of its subsidiaries or any Enterprise) and Indemnitee. Indemnitee specifically acknowledges that any employment
with the Company (or any of its subsidiaries or any Enterprise) is at will, and Indemnitee may be discharged at any time for any reason, with or without cause, with or without notice, except as may be otherwise expressly provided in any executed,
written employment contract between Indemnitee and the Company (or any of its subsidiaries or any Enterprise), any existing formal severance policies adopted by the Company’s board of directors or, with respect to service as a director or
officer of the Company, the Company’s certificate of incorporation or bylaws or the DGCL. No such document shall be subject to any oral modification thereof. 

20. Duration. This Agreement shall continue until and terminate upon the later of (a) ten years after the date that
Indemnitee shall have ceased to serve as a director or officer of the Company or as a director, trustee, general partner, managing member, officer, employee, agent or fiduciary of any other Enterprise, as applicable; or (b) one year after the
final termination of any Proceeding, including any appeal, then pending in respect of which Indemnitee is granted rights of indemnification or advancement of Expenses hereunder and of any proceeding commenced by Indemnitee pursuant to
Section 12 of this Agreement relating thereto. 
 21. Successors. This Agreement shall be binding upon the Company
and its successors and assigns, including any direct or indirect successor by purchase, merger, consolidation or otherwise to all or substantially all of the business or assets of the Company, and shall inure to the benefit of Indemnitee and
Indemnitee’s heirs, executors and administrators. The Company shall require and cause any successor (whether direct or indirect by purchase, merger, consolidation or otherwise) to all or substantially all of the business or assets of the
Company, by written agreement, expressly to assume and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform if no such succession had taken place. 

  
 -12- 

 22. Severability. Nothing in this Agreement is intended to require or shall be
construed as requiring the Company to do or fail to do any act in violation of applicable law. The Company’s inability, pursuant to court order or other applicable law, to perform its obligations under this Agreement shall not constitute a
breach of this Agreement. If any provision or provisions of this Agreement shall be held to be invalid, illegal or unenforceable for any reason whatsoever: (i) the validity, legality and enforceability of the remaining provisions of this
Agreement (including without limitation, each portion of any section of this Agreement containing any such provision held to be invalid, illegal or unenforceable, that is not itself invalid, illegal or unenforceable) shall not in any way be affected
or impaired thereby and shall remain enforceable to the fullest extent permitted by law; (ii) such provision or provisions shall be deemed reformed to the extent necessary to conform to applicable law and to give the maximum effect to the
intent of the parties hereto; and (iii) to the fullest extent possible, the provisions of this Agreement (including, without limitation, each portion of any section of this Agreement containing any such provision held to be invalid, illegal or
unenforceable, that is not itself invalid, illegal or unenforceable) shall be construed so as to give effect to the intent manifested thereby. 

23. Enforcement. The Company expressly confirms and agrees that it has entered into this Agreement and assumed the obligations
imposed on it hereby in order to induce Indemnitee to serve as a director or officer of the Company, and the Company acknowledges that Indemnitee is relying upon this Agreement in serving as a director or officer of the Company. 

24. Entire Agreement. This Agreement constitutes the entire agreement between the parties hereto with respect to the subject
matter hereof and supersedes all prior agreements and understandings, oral, written and implied, between the parties hereto with respect to the subject matter hereof; provided, however, that this Agreement
is a supplement to and in furtherance of the Company’s certificate of incorporation and bylaws and applicable law. 
 25.
Modification and Waiver. No supplement, modification or amendment to this Agreement shall be binding unless executed in writing by the parties hereto. No amendment, alteration or repeal of this Agreement shall adversely affect any right of
Indemnitee under this Agreement in respect of any action taken or omitted by such Indemnitee in his or her Corporate Status prior to such amendment, alteration or repeal. No waiver of any of the provisions of this Agreement shall constitute or be
deemed a waiver of any other provision of this Agreement nor shall any waiver constitute a continuing waiver. 
 26.
Notices. All notices and other communications required or permitted hereunder shall be in writing and shall be mailed by registered or certified mail, postage prepaid, or otherwise delivered by hand, messenger or courier service addressed:

 (a) if to Indemnitee, to Indemnitee’s address, as shown on the signature page of this Agreement or in the Company’s
records, as may be updated in accordance with the provisions hereof; or 

  
 -13- 

 (b) if to the Company, to the attention of the Chief Executive Officer or Chief Financial Officer
of the Company at 4440 El Camino Real, Los Altos, California 94022, or at such other current address as the Company shall have furnished to Indemnitee, with a copy (which shall not constitute notice) to Steven E. Bochner, Jose F. Macias, and, Jon C.
Avina at Wilson Sonsini Goodrich & Rosati, P.C., 650 Page Mill Road, Palo Alto, California 94304. 
 Each such notice or other
communication shall for all purposes of this Agreement be treated as effective or having been given (i) if delivered by hand, messenger or courier service, when delivered (or if sent via a nationally-recognized overnight courier service,
freight prepaid, specifying next-business-day delivery, one business day after deposit with the courier), or (ii) if sent via mail, at the earlier of its receipt or five days after the same has been deposited in a regularly-maintained
receptacle for the deposit of the United States mail, addressed and mailed as aforesaid. 
 27. Applicable Law and Consent to
Jurisdiction. This Agreement and the legal relations among the parties shall be governed by, and construed and enforced in accordance with, the laws of the State of Delaware, without regard to its conflict of laws rules. Except with respect to
any arbitration commenced by Indemnitee pursuant to Section 12(a) of this Agreement, or except as mutually agreed by the parties in writing, the Company and Indemnitee hereby irrevocably and unconditionally (i) agree that any action or
proceeding arising out of or in connection with this Agreement shall be brought only in the Delaware Court of Chancery, and not in any other state or federal court in the United States of America or any court in any other country, (ii) consent
to submit to the exclusive jurisdiction of the Delaware Court of Chancery for purposes of any action or proceeding arising out of or in connection with this Agreement, (iii) appoint, to the extent such party is not otherwise subject to service
of process in the State of Delaware, The Corporation Trust Company, Wilmington, Delaware as its agent in the State of Delaware as such party’s agent for acceptance of legal process in connection with any such action or proceeding against such
party with the same legal force and validity as if served upon such party personally within the State of Delaware, (iv) waive any objection to the laying of venue of any such action or proceeding in the Delaware Court of Chancery, and
(v) waive, and agree not to plead or to make, any claim that any such action or proceeding brought in the Delaware Court of Chancery has been brought in an improper or inconvenient forum. 

28. Counterparts. This Agreement may be executed in one or more counterparts, each of which shall for all purposes be deemed to
be an original but all of which together shall constitute one and the same Agreement. This Agreement may also be executed and delivered by facsimile signature and in counterparts, each of which shall for all purposes be deemed to be an original but
all of which together shall constitute one and the same Agreement. Only one such counterpart signed by the party against whom enforceability is sought needs to be produced to evidence the existence of this Agreement. 

29. Captions. The headings of the paragraphs of this Agreement are inserted for convenience only and shall not be deemed to
constitute part of this Agreement or to affect the construction thereof. 
 (signature page follows) 

  
 -14- 

 The parties are signing this Indemnification Agreement as of the date stated in the introductory
sentence. 
  

	
	BOX, INC.
	
	  

	(Signature)
	
	  

	(Print Name)
	
	  

	(Title)
	
	INDEMNITEE
	
	  

	(Signature)
	
	  

	(Print Name)
	
	  

	(Street address)
	
	  

	(City, State and ZIP)

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00232-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00232-of-00352.parquet"}]]